
<html lang="en"     class="pb-page"  data-request-id="ae9a52b5-6ffc-44f8-966b-ca5d0ead0710"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2013.56.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm3008745"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα" /></meta><meta name="dc.Creator" content="Mariana  Nacht" /></meta><meta name="dc.Creator" content="Lixin  Qiao" /></meta><meta name="dc.Creator" content="Michael P.  Sheets" /></meta><meta name="dc.Creator" content="Thia  St. Martin" /></meta><meta name="dc.Creator" content="Matthew  Labenski" /></meta><meta name="dc.Creator" content="Hormoz  Mazdiyasni" /></meta><meta name="dc.Creator" content="Russell  Karp" /></meta><meta name="dc.Creator" content="Zhendong  Zhu" /></meta><meta name="dc.Creator" content="Prasoon  Chaturvedi" /></meta><meta name="dc.Creator" content="Deepa  Bhavsar" /></meta><meta name="dc.Creator" content="Deqiang  Niu" /></meta><meta name="dc.Creator" content="William  Westlin" /></meta><meta name="dc.Creator" content="Russell C.  Petter" /></meta><meta name="dc.Creator" content="Aravind Prasad  Medikonda" /></meta><meta name="dc.Creator" content="Juswinder  Singh" /></meta><meta name="dc.Description" content="PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα. We de..." /></meta><meta name="Description" content="PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα. We de..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 5, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3008745" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3008745" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3008745" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3008745" /></link>
        
    
    

<title>Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3008745" /></meta><meta property="og:title" content="Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0008.jpeg" /></meta><meta property="og:description" content="PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα. We demonstrate, using mass spectrometry and X-ray crystallography, that the selective inhibitor covalently modifies PI3Kα on cysteine 862 (C862), an amino acid unique to the α isoform, and that PI3Kβ, -γ, and -δ are not covalently modified. 3 is able to potently (EC50 &lt; 100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a potent antiproliferative effect (GI50 &lt; 100 nM). A covalent probe, 8 (CNX-1220), which selectively bonds to PI3Kα, was used to investigate the duration of occupancy of 3 with PI3Kα in vivo. This is the first report of a PI3Kα-selective inhibitor, and these data demonstrate the biological impact of selectively targeting PI3Kα." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3008745"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3008745">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3008745&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3008745&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3008745&amp;href=/doi/10.1021/jm3008745" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 712-721</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301614w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300938r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mariana++Nacht">Mariana Nacht</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixin++Qiao">Lixin Qiao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+P.++Sheets">Michael P. Sheets</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thia++St.+Martin">Thia St. Martin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Labenski">Matthew Labenski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hormoz++Mazdiyasni">Hormoz Mazdiyasni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell++Karp">Russell Karp</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhendong++Zhu">Zhendong Zhu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prasoon++Chaturvedi">Prasoon Chaturvedi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepa++Bhavsar">Deepa Bhavsar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deqiang++Niu">Deqiang Niu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Westlin">William Westlin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell+C.++Petter">Russell C. Petter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aravind+Prasad++Medikonda">Aravind Prasad Medikonda</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juswinder++Singh">Juswinder Singh</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Celgene Avilomics Research, 45 Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 781-541-3700. Fax: 781-541-5101. E-mail: <a href="/cdn-cgi/l/email-protection#44292a25272c300427212823212a216a272b29"><span class="__cf_email__" data-cfemail="375a5956545f437754525b505259521954585a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3008745&amp;href=/doi/10.1021%2Fjm3008745" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 712–721</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 29, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 June 2012</li><li><span class="item_label"><b>Published</b> online</span>5 February 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3008745" title="DOI URL">https://doi.org/10.1021/jm3008745</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D712%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMariana%2BNacht%252C%2BLixin%2BQiao%252C%2BMichael%2BP.%2BSheets%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D3%26contentID%3Djm3008745%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BIsoform-Selective%2BTargeted%2BCovalent%2BInhibitor%2Bof%2Bthe%2BLipid%2BKinase%2BPI3K%25CE%25B1%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D721%26publicationDate%3DFebruary%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3008745"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4465</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3008745" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mariana&quot;,&quot;last_name&quot;:&quot;Nacht&quot;},{&quot;first_name&quot;:&quot;Lixin&quot;,&quot;last_name&quot;:&quot;Qiao&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;P. Sheets&quot;},{&quot;first_name&quot;:&quot;Thia&quot;,&quot;last_name&quot;:&quot;St. Martin&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Labenski&quot;},{&quot;first_name&quot;:&quot;Hormoz&quot;,&quot;last_name&quot;:&quot;Mazdiyasni&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;Karp&quot;},{&quot;first_name&quot;:&quot;Zhendong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Prasoon&quot;,&quot;last_name&quot;:&quot;Chaturvedi&quot;},{&quot;first_name&quot;:&quot;Deepa&quot;,&quot;last_name&quot;:&quot;Bhavsar&quot;},{&quot;first_name&quot;:&quot;Deqiang&quot;,&quot;last_name&quot;:&quot;Niu&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Westlin&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;C. Petter&quot;},{&quot;first_name&quot;:&quot;Aravind&quot;,&quot;last_name&quot;:&quot;Prasad Medikonda&quot;},{&quot;first_name&quot;:&quot;Juswinder&quot;,&quot;last_name&quot;:&quot;Singh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;712-721&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3008745&quot;},&quot;abstract&quot;:&quot;PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα. We demonstrate, using mass spectrometry and X-ray crystallography, that the selective inhibitor covalently modifies PI3Kα on cysteine 862 (C862), an amino acid unique to the α isoform, and that PI3Kβ, -γ, and -δ are not covalently modified. 3 is able to potently (EC50 &lt; 100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a potent antiproliferative effect (GI50 &lt; 100 nM). A covalent probe, 8 (CNX-1220), which selectively bonds to PI3Kα, was used to investigate the duration of occupancy of 3 with PI3Kα in vivo. This is the first report of a PI3Kα-selective inhibitor, and these data demonstrate the biological impact of selectively targeting PI3Kα.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008745&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008745" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008745&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008745" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008745&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008745" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3008745&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008745&amp;href=/doi/10.1021/jm3008745" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3008745" /></input><a href="/doi/pdf/10.1021/jm3008745" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3008745%26sid%3Dliteratum%253Aachs%26pmid%3D23360348%26genre%3Darticle%26aulast%3DNacht%26date%3D2013%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BIsoform-Selective%2BTargeted%2BCovalent%2BInhibitor%2Bof%2Bthe%2BLipid%2BKinase%2BPI3K%25CE%25B1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D3%26spage%3D712%26epage%3D721%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jmcmar.2013.56.issue-3/production/jmcmar.2013.56.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design, a targeted covalent inhibitor <b>3</b> (CNX-1351) was created that potently and specifically inhibits PI3Kα. We demonstrate, using mass spectrometry and X-ray crystallography, that the selective inhibitor covalently modifies PI3Kα on cysteine 862 (C862), an amino acid unique to the α isoform, and that PI3Kβ, -γ, and -δ are not covalently modified. <b>3</b> is able to potently (EC<sub>50</sub> < 100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a potent antiproliferative effect (GI<sub>50</sub> < 100 nM). A covalent probe, <b>8</b> (CNX-1220), which selectively bonds to PI3Kα, was used to investigate the duration of occupancy of <b>3</b> with PI3Kα in vivo. This is the first report of a PI3Kα-selective inhibitor, and these data demonstrate the biological impact of selectively targeting PI3Kα.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The structure of <b>3</b> complexed with PI3Kα has been deposited in the Protein Data Bank, and the PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zim">3zim</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The family of lipid phosphoinositide 3-kinases (PI3Ks) plays a key regulatory role in many cellular processes including proliferation, cell survival, differentiation, and metabolism (reviewed in refs <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">1</a> and <a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">2</a>). There are three classes of PI3Ks. The class I family is the best studied and the family most implicated in cancer cell growth. The class I PI3Ks are heterodimers consisting of a p110 catalytic subunit and a p85 regulatory subunit. The PI3K class I family consists of four isoforms, α, β, γ, and δ. PI3Ks α and β are ubiquitously expressed, whereas expression of γ and δ is more restricted, mostly to leukocytes. The lipid kinases convert phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-trisphosphate, and the process is reversed by the phosphatase and tumor suppressor protein PTEN.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> In recent years, activated class I<sub>A</sub> PI3K signaling has been increasingly linked to cancer. PI3K can be activated by receptor tyrosine kinase (RTK) signaling<a onclick="showRef(event, 'ref1 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref6 ref7">(1, 5-7)</a> and inactivation of the negative regulator PTEN,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and through direct somatic mutations in <i>PIK3CA</i>, the gene that encodes the p110α subunit of PI3K.<a onclick="showRef(event, 'ref1 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref9">(1, 9)</a><i>PIK3CA</i> is mutated in up to 30% of human cancers, including breast, colon, prostate, and endometrial cancers.<a onclick="showRef(event, 'ref1 ref10'); return false;" href="javascript:void(0);" class="ref ref1 ref10">(1, 10)</a> Importantly, it has been demonstrated that these mutations are in fact oncogenic.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">Several PI3K inhibitors are currently in clinical development, but most are pan-PI3K inhibitors that bind reversibly to the ATP site.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The human tumor genetic data suggest that mutations in PI3Kα drive tumor growth and therefore support the need for a PI3Kα selective inhibitor. Moreover, a selective inhibitor that does not bind to β, δ, and γ may spare toxicities caused by prevention of platelet aggregation and activation,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> inhibition of immune responses mediated by T, B, and mast cells,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and blocking anti-inflammatory signals,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> respectively. Recently, there has been a resurgence of interest in the use of covalent inhibitors to address challenges in potency and selectivity to drug targets.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> There are many examples of covalent drugs that have proven to be safe and successful therapies for a wide variety of indications, including blockbuster drugs such as esomeprazole (AstraZeneca) and clopidogrel (Sanofi-Aventis/Bristol-Myers Squibb).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The majority of these covalent drugs have been discovered serendipitously, but recently there has been progress in the rational design of covalent drugs, termed targeted covalent inhibitors, which has been described mainly in the area of kinases<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and more recently in the protease field.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Here we describe the first example of a targeted covalent inhibitor of the lipid kinase family that is an isoform-selective inhibitor of PI3Kα.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Design of a Targeted Covalent Inhibitor of PI3Kα</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A major challenge in the design of isoform-selective PI3K inhibitors has been the high similarity of the lipid kinase ATP binding sites. We examined the ATP binding site and nearby residues of PI3Kα to identify opportunities for selective covalent modification. Our design strategy was to use the binding mode of the reversible pan-PI3K inhibitor GDC-0941<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to create a targeted covalent inhibitor. The binding mode of GDC-0941 to PI3Kγ had been determined by X-ray crystallography, and we used molecular modeling to model the binding of GDC-0941 to the X-ray structure of PI3Kα.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> By aligning the PI3Kα model with the X-ray complex of PI3Kγ, we identified C862 as a promising amino acid to target, since it is near the small molecule binding site (∼10 Å), provides a relatively strong nucleophilic center, and is unique to PI3Kα (it is not present in β, γ, and δ; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). Through a series of design cycles exploring both linker spacing and electrophilic functional groups, we identified <b>3</b> (CNX-1351) as a targeted covalent inhibitor of PI3Kα (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). In addition, we developed an irreversible biotinylated covalent probe <b>8</b> (CNX-1220; see Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) that allows for the measurement of free protein versus bound target protein.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding site sequence and structure of PI3Kα complexed with compound <b>3</b>. (a) Binding site composition of class 1 PI3K isoforms α, β, γ, and δ. (b) X-ray complex of <b>3</b> to PI3Kα. The protein backbone is shown as a cartoon. The structure of <b>3</b> is shown as a stick representation, and the binding site residues are shown as lines. Hydrogen bonds between <b>3</b> and the protein are shown as dashed lines. C862 is highlighted, as well as D810, Y836, and V851 (hinge region) which are involved in hydrogen bonds with the inhibitor. (c) Overlay of <b>3</b>–PI3Kα (yellow) X-ray complex with X-ray complex of GDC-0941 bound to PI3Kγ (3DBS, Ggreen). (d) Electron density of <b>3</b> bound to PI3Kα. The ligand and neighboring protein side chains are shown as a stick model, colored according to the chemical atom type (<b>3</b> in cyan, human PI3K in gray, N in blue, O in red, and S in yellow). The ligand molecule is shown superimposed with the refined 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map contoured at 1.0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 2D chemical structure of (a) compound <b>3</b> and (b) GDC-0941.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic approach for the covalent inhibitor <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a) is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Thienopyrimidyl chloride <b>1</b> was prepared using methods similar to those reported for GDC-0941 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Compound <b>1</b> then underwent Suzuki coupling with (1<i>H</i>-indazol-4-yl)boronic acid to give 4-indazolylthienopyrimidine <b>2</b>. After Boc deprotection, the resulting piperazine was acylated with carbonyldiimidazole-activated 6-methyl-4-oxohept-5-enoic acid, which delivered the desired <i>gem</i>-dimethylenone compound <b>3</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) (1<i>H</i>-indazol-4-yl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, DMA, microwave, 120 °C, 1 h, 73%; (b) HCl in dioxane, DCM–MeOH, 100%; (c) 6-methyl-4-oxohept-5-enoic acid, carbonyl diimidazole, DMA, rt, 45 min; then de-Boc intermediate, DIPEA, DMA, rt, overnight, 62%.</p></p></figure><div class="NLM_p">The biotinylated covalent probe <b>8</b>, was designed to measure the occupancy of PI3Kα by covalent inhibitors (i.e., <b>3</b>). The synthesis of <b>8</b> is described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound <b>1</b> was treated with 3-hydroxyphenylboronic acid under Suzuki conditions to give phenol <b>5</b>. Upon deprotection, the resulting piperazine was treated with 5-(diethoxyphosphoryl)-4-oxopentanoic acid <b>4</b>, which was prepared by condensing succinic anhydride with deprotonated diethyl methylphosphonate. The resulting phosphonate <b>6</b> subsequently underwent Wittig–Horner–Emmons reaction with <i>tert</i>-butyl 4-formylbenzylcarbamate, giving <i>trans</i>-enone <b>7</b> only. Final assembly of covalent probe <b>8</b> was achieved via de-Boc of compound <b>7</b> followed by amide formation with commercially available polyethylene glycol linked biotin glutaric acid.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) 3-hydroxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/ethanol/H<sub>2</sub>O, 120 °C, 1 h, 69%; (b) HCl in dioxane, DCM–MeOH, 100%; (c) compound <b>3</b>, carbonyldiimidazole, DMA, rt, 45 min; then de-Boc intermediate, DIPEA, DMA, rt, overnight, 47%; (d) K<sub>2</sub>CO<sub>3</sub>, DMA–H<sub>2</sub>O, 70 °C, 4 h; (e) CF<sub>3</sub>CO<sub>2</sub>H, dichloromethane; (f) <i>N</i>-biotinyl-NH-(PEG)<sub>2</sub>-COOH-DIPEA (20 atoms), HATU, DIPEA, DMA.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mass spectrometry was used to confirm that <b>3</b> covalently bonds to PI3Kα but not to the other class I isoforms (see Figure S2a in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). To confirm that C862 was the amino acid on which the bond was formed, PI3Kα protein was incubated with <b>3</b> and then subjected to tryptic digestion. Subsequent peptide analysis of the digested, modified protein confirmed modification of C862 (see Figure S2b in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">Using X-ray crystallography, we confirmed our predicted binding mode of <b>3</b> to PI3Kα (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b). The X-ray complex of GDC-0941 has been described previously, binding to PI3Kβ, -γ, and δ, and has been shown to adopt a three-point binding mode to the PI3K ATP site.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Comparison of the published binding mode of GDC-0941 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>) with our X-ray complex of <b>3</b> to PI3Kα shows similar binding modes in the PI3K ATP binding site but also important differences (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c). The two compounds adopt a similar packing arrangement of the thienopyrimidine core. Both employ the morpholine oxygen to form a hydrogen bond with the hinge region and place the indazole into the affinity pocket. There are differences in the binding mode of the substituted piperazine functionality between the two compounds. Unlike the binding mode of GDC-0941, in which the piperazine is kinked out of the plane relative to the thienopyrimidine core and packs against Arg770 and Ser773, the substituted piperazine of <b>3</b> is directed toward the other side of the binding site toward the side chain of C862. The dimethylenone is clearly seen in the electron density to form a covalent bond with C862 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>d).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Compound <b>3</b> Is a Selective Covalent Inhibitor of PI3Kα</h3><div class="NLM_p">The biochemical potency and selectivity of <b>3</b> were examined. <b>3</b> was tested against all four of the class I PI3K enzymes α, β, γ, and δ. In an end point assay, <b>3</b> potently inhibited PI3Kα and was 20–400 times less potent against β, γ, and δ (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Because of the irreversible mechanism of action, <b>3</b> shows time-dependent inhibition. Thus, IC<sub>50</sub> apparents are used to report the inhibitory activity of <b>3</b> at a given time point. <b>3</b> showed even greater selectivity against the class II lipid kinases, none of which were appreciably inhibited at the highest concentration of drug tested (1 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Moreover, <b>3</b> was tested against a panel of 60 kinases, representing all branches of the kinome tree, and showed excellent selectivity; no kinases were inhibited by greater than 40% using 1 μM compound (see Table S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), suggesting that <b>3</b> is a very selective PI3Kα inhibitor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Selectivity of Compound <b>3</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50_</sub>App <a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kα</td><td class="colsep0 rowsep0" align="left">6.8 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kβ</td><td class="colsep0 rowsep0" align="left">166.0 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kγ</td><td class="colsep0 rowsep0" align="left">240.3 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Kδ</td><td class="colsep0 rowsep0" align="left">3020.0 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3KC2A</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3KC3</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI4Kα</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI4Kβ</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SPHK1</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SPHK2</td><td class="colsep0 rowsep0" align="left">>1 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Compound <b>3</b> was tested in a panel of 10 lipid kinases, and an IC<sub>50</sub> apparent was determined (IC<sub>50_</sub>App).</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Irreversible inhibitors show time-dependent inhibition. Thus, an IC<sub>50</sub> apparent is used to determine the inhibitory activity of irreversible molecules at a given time point.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Compound <b>3</b> Shows No Reactivity toward Glutathione or Abundant Human Plasma Proteins</h3><div class="NLM_p">The off-target reactivity of <b>3</b> was assessed using mass spectrometry methods. <b>3</b> was reacted with a 500-fold molar excess of glutathione (GSH), a tripeptide and abundant intracellular thiol, in a metabolism-free setting to determine whether the dimethylenone of <b>3</b> would react with the thiol present in GSH. After 2 h at 37 °C, >80% of free <b>3</b> was recovered, consistent with the no-GSH control samples (see Figure S3a in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This indicates that <b>3</b> is not indiscriminately reactive toward GSH.</div><div class="NLM_p last"><b>3</b> was incubated in albumin-depleted human plasma at 37 °C for 1 or 3 h to determine whether it would covalently bond with any highly abundant human plasma proteins. None of the observed human plasma proteins showed mass shifts consistent with the mass of <b>3</b>, suggesting an inability to covalently modify these off-target plasma proteins at detectable levels (see Figure S3b in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>3</b> Inhibits PI3Kα Signaling in Cells and Shows Prolonged Inhibition Consistent with a Covalent Mechanism of Action</h3><div class="NLM_p">SKOV3 ovarian cancer cells have a mutation in <i>PIK3CA</i> that results in a constitutively activated PI3Kα signaling pathway.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These cells were used to examine if <b>3</b> could inhibit P-Akt<sup>Ser473</sup> as a measure of inhibition of PI3K signaling. <b>3</b> (1–1000 nM) was added to SKOV3 cells for 1 h. Lysates of the cells were interrogated by immunoblot analysis for P-Akt<sup>Ser473</sup>. A noncovalent pan-PI3K inhibitor, GDC-0941, was used as a control and demonstrates that <b>3</b> inhibits PI3K signaling in SKOV3 cells, with potency (EC<sub>50</sub> of 10–100 nM; see Figure S4 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) similar to that of the pan-PI3K inhibitor.</div><div class="NLM_p">To demonstrate the covalent mechanism of action in cells, SKOV3 cells were transiently treated with the covalent inhibitor, and prolonged inhibition of P-Akt<sup>Ser473</sup> was examined. SKOV3 cells were incubated with <b>3</b> or the reversible inhibitor GDC-0941 (500 nM each) for 1 h. Cells were washed, and medium was replaced with fresh compound-free medium at regular intervals (approximately once every hour for 3 h). Cell lysates were prepared at 1, 6, and 24 h after compound removal. Cell lysates were interrogated by immunoblot analysis for P-Akt<sup>Ser473</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). As expected, signaling returned immediately after removal of the reversible inhibitor, GDC-0941, but was inhibited >6 h after removal of <b>3</b>, consistent with the activity of an irreversible compound.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of p-Akt<sup>Ser473</sup> continues after removal of compound <b>3</b>. SKOV-3 cells were incubated with <b>3</b> or GDC-0941 (500 nM each) for 1 h. Medium was replaced with fresh compound-free medium at regular intervals, and cell lysates were prepared at the indicated times after compound removal. Cells were processed for in-cell Western analysis (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) to determine expression of P-Akt<sup>Ser473</sup>. Signaling returned immediately after removal of the reversible inhibitor, GDC-0941, but was inhibited >6 h after removal of <b>3</b>. Data shown are from duplicates. Experiment was performed at least 3 times: (∗∗) <i>p</i> < 0.001; (∗) <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>3</b> Inhibits Growth of Cells Dependent on PI3Kα</h3><div class="NLM_p">To investigate the functional consequence of inhibiting PI3Kα in cells, two cell lines with different <i>PIK3CA</i> activating mutations, SKOV3 ovarian cancer cells (H1047R) and MCF-7 breast cancer cells (E545K), were treated with <b>3</b> and growth was monitored. Both <i>PIK3CA</i>-driven cell lines were growth inhibited by exposure to <b>3</b> for 96 h (GI<sub>50</sub> of 78 and 55 nM, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These data suggest that selective inhibition of PI3Kα will lead to an antiproliferative effect on <i>PIK3CA</i>-driven tumors.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Compound <b>3</b> Inhibits Growth of Cells Dependent on PI3Kα<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">GI<sub>50</sub> ± SEM (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">SKOV3 (PIK3CA<sup>H1047R</sup>)</th><th class="colsep0 rowsep0" align="center">MCF-7 (PIK3CA<sup>E545K</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GDC-0941</td><td class="colsep0 rowsep0" align="left">147.6 ± 36.6</td><td class="colsep0 rowsep0" align="left">70.2 ± 13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">77.6 ± 16.8</td><td class="colsep0 rowsep0" align="left">54.7 ± 14.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Cells with activating mutations in PI3KCA (H1047R or E545K) were growth inhibited by the PI3Kα selective compound <b>3</b> or the pan-PI3K inhibitor GDC-0941. Tumor cells (3000–7000 cells/well) were placed in a 96-well plate and allowed to settle for 5 h. Compounds were serially diluted (1 μM to 4 nM) and added to the cells. After a 96 h incubation, cell viability was measured using Cell Titer-Glo (Promega) to determine the growth inhibition. Data shown are an average of four experiments, each performed in duplicate.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>3</b> Inhibits PI3Kα Signaling in Vivo and Bonds to p110α</h3><div class="NLM_p">To examine the activity of <b>3</b> on PI3Kα signaling in vivo, <b>3</b> was delivered to nude mice (100 mg/kg ip) once a day for 5 consecutive days. Because PI3Kα is ubiquitously expressed, spleens were harvested from the mice at 1, 4, and 24 h after the last administration of compound to measure the impact of <b>3</b> on PI3K signaling. Lysates from the spleens were immunoblotted for P-Akt<sup>Ser473</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). Inhibition of PI3K signaling was detected as a decrease in P-Akt<sup>Ser473</sup> at 1 and 4 h after the last dose.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3</b> inhibited p-Akt<sup>Ser473</sup> in mouse spleens and bonds to PI3Kα in vivo. Compound <b>3</b> was delivered into the intraperitoneal cavity of nude mice at 100 mg/kg once a day for 5 consecutive days (<i>n</i> = 3 mice per group). Spleens were harvested from the mice at the indicated times after the last dose (1–24 h) and interrogated by immunoblot for P-Akt<sup>Ser473</sup> (a) or for PI3Kα occupancy (b) as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Inhibition of PI3K signaling was detected as a decrease in P-Akt<sup>Ser473</sup> at 1 and 4 h after last dose. Similarly, there was little/no free PI3Kα at 1 and 4 h after the last dose ((∗∗) <i>p</i> < 0.001). Protein resynthesis accounts for the return of free protein and signaling activity at 24 h ((∗∗) <i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An irreversible covalent inhibitor allows for the measurement of free protein versus bound target protein using a covalent probe that bonds only to free protein. A biotinylated covalent probe that is selective for p110α (<b>8</b>; see Figure S5a and Figure S5b in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) was used to detect free, uninhibited p110α in spleen cells. There was little free p110α at 1 and 4 h after the last dose, indicating that <b>3</b> irreversibly bonded to p110α in vivo (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). At 24 h after the final dose, free p110α was detectable because of protein resynthesis, concomitant with the return of P-Akt<sup>Ser473</sup> expression.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This is the first detailed report of a selective covalent inhibitor of PI3Kα. Recently, Novartis and Intellikine launched phase I clinical trials for α-selective inhibitors (BYL719 and INK1117, respectively, AACR 2012), but detailed reports of these drugs have not been published. Our data demonstrate that the application of a targeted covalent inhibitor strategy to PI3Kα has a number of unique features related to the covalent mechanism of action. The targeting of a Cys which is present in PI3Kα but not in the other isoforms has enabled us to achieve selective covalent inhibition of PI3Kα. This is in contrast to the natural product wortmannin, which is also a covalent inhibitor of the PI3K family but which targets a conserved Lys and therefore shows no isoform selectivity.</div><div class="NLM_p">This is also the first reported X-ray structure of a targeted covalent inhibitor to the lipid kinase family. Our predicted binding model of <b>3</b> was in good agreement with the PI3Kα X-ray crystal structure that we determined. We have recently compared the reactivity and geometry of the β,β-dimethylenone that is present in <b>3</b> with other five α,β-unsaturated ketones using high level quantum mechanical calculations.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The β,β-dimethylenone showed the highest activation barrier in aqueous solution, indicating that it is a highly stable electrophile compared to α- or β-methylenone and α,β-dimethylenone. The covalent mechanism of action enables complete and durable inhibition of PI3Kα, which leads to silencing of the target protein and its downstream oncogenic signaling. Our data show that the inhibition of PI3Kα persists even after washout of drug, which could enable less frequent dosing and minimize off-target activity. Less frequent dosing coupled with specificity toward the α isoform may enable a higher therapeutic index by sparing potential toxicities from pan inhibition of this central lipid kinase family with pleiotropic functions. Another important benefit of the covalent strategy is the companion covalent probe that was used preclinically to assess occupancy of PI3Kα in vivo and could be a powerful translational tool in assessing PK/PD in the clinic.</div><div class="NLM_p last"><b>3</b> is a powerful tool compound that will allow several important questions about PI3K biology to be addressed. The selectivity for PI3Kα and the prolonged duration of inhibition will allow the investigation of the role of PI3Kα in different tumor models with different genetic contexts. Moreover, there are reports regarding the contribution of α and β to glucose homeostasis offering diverging conclusions; a selective α inhibitor may resolve these open questions. Although <b>3</b> has useful properties as a tool compound, it also has deficiencies as a lead compound. The pharmacokinetic properties of the compound are suboptimal and are the focus of a medicinal chemistry effort to improve its oral bioavailability while maintaining its potency and selectivity. This will be the focus of a future publication. Finally, emerging clinical data support the notion that combinations of targeted therapies may be more effective than monotherapy and may help reduce the emergence of drug resistance. Thus, a selective and durable inhibitor of PI3Kα may be a very important component of future combination approaches.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry. General Experimental Details</h3><div class="NLM_p">All commercial reagents and anhydrous solvents were obtained from commercial sources and were used without further purification unless otherwise specified.</div><div class="NLM_p last">Microwave chemistry was done using CEM Explorer. LC–MS was used to analyze the purity of all compounds on an Agilent LC-1200 series coupled with Agilent 6120 quadruple mass spectrometer. The mobile phase for all mass analysis consisted of acetonitrile–water mixtures with 5 mM ammonium acetate and 5 mM acetic acid. All final compounds were greater than 95% pure. Preparative reverse-phase chromatography was carried out using using a Prep Varian ProStar model 210 on a Microsorb-MV 100-8 C18 Dynamax 250 mm × 21.4 mm column with a linear gradient from 10% to 90% CH<sub>3</sub>CN in H<sub>2</sub>O over 20 min (0.1% trifluoroacetic acid) and a flow rate of 20 mL/min. <sup>1</sup>H and <sup>13</sup>C NMR spectra (δ, ppm) were recorded on a JEOL AMX-400 (400 MHz) or Bruker AVANCE-3 (400 MHz) instrument. High-resolution mass spectra were measured using a Waters Q-Tof Premier operating in +ESI W-mode.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>tert</i>-Butyl 4-((2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazine-1-carboxylate (<b>1</b>)</h3><div class="NLM_p last">2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidine-6-carbaldehyde (0.40 g, 1.5 mmol), <i>tert</i>-butylpiperazine 1-carboxylate, and 0.2 mL of acetic acid were dissolved in 12 mL of dichloroethane. The mixture was stirred at room temperature for 2 h. NaBH(OAc)<sub>3</sub> (0.54g, 2.5 mmol) was added to the reaction mixture, and the resulting mixture was stirred at room temperature for 10 h. Then 20 mL of NaHCO<sub>3</sub> aqueous solution and 10 mL of DCM were added. The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. After removal of solvent, the crude product was subjected to chromatography on silica gel (eluent, EtOAc/hexane 3:7). A total of 0.30 g of the title compound was obtained. MS: <i>m</i>/<i>z</i> 454.2 (M + H). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.16 (s, 1H), 4.37 (q, <i>J</i> = 4.4 Hz, 4H), 3.90 – 3.78 (m, 6H), 3.46 (t, <i>J</i> = 4.8 Hz, 4H), 2.49 (t, <i>J</i> = 4.8 Hz, 4H), 1.45 (s, 9H) ppm.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>tert</i>-Butyl 4-((2-(1<i>H</i>-Indazol-4-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazine-1-carboxylate (<b>2</b>)</h3><div class="NLM_p last">To a 10 mL microwave tube were added Boc-piperazine <b>1</b> (91 mg, 0.20 mmol), (1<i>H</i>-indazol-4-yl)boronic acid (40 mg, 0.25 mmol), Na<sub>2</sub>CO<sub>3</sub> (84 mg, 0.79 mmol) with 1.6 mL of degassed <i>N</i>,<i>N</i>-dimethylacetamide, and 0.4 mL of degassed water, followed by Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (8.2 mg, 0.01 mmol). The whole system was repurged with nitrogen and then heated in a microwave reactor at 120 °C for 1 h. The reaction mixture was diluted with water and extracted with dichloromethane (DCM). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After the removal of solvent under reduced pressure, the crude material was purified by silica gel column chromatography (DCM/MeOH v/v 30/1) to afford compound <b>2</b> (78 mg, 73%) as slight yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.0 (s, 1H), 8.26 (d, <i>J</i> = 6.8 Hz, 1H), 7.6–7.5 (m, 3H), 7.38 (s, 1H), 4.15–4.06 (m, 4H), 3.98–3.75 (m, 6H), 3.48 (t, <i>J</i> = 4.6 Hz, 4H), 2.60–2.43 (m, 4H), 1.46 (s, 9H) ppm. MS: <i>m</i>/<i>z</i> 536.1 [M + H].</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-(4-((2-(1<i>H</i>-Indazol-4-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazin-1-yl)-6-methylhept-5-ene-1,4-dione (<b>3</b>)</h3><div class="NLM_p">To a stirred solution of compound <b>2</b> (54 mg, 0.1 mmol) in 1 mL of DCM and 1 mL of MeOH was added 4 M HCl in dioxane (2 mL), and the resulting reaction mixture was stirred at room temperature for 1 h. The solvent was then removed under reduced pressure, and the residue was dried in vacuum and used directly for the following step. MS: <i>m</i>/<i>z</i> 436.1 (M + H).</div><div class="NLM_p last">6-Methyl-4-oxohept-5-enoic acid (17 mg, 0.11 mmol) and carbonyldiimidazole (17 mg, 0.11 mmol) were mixed in 0.5 mL of <i>N</i>,<i>N</i>-dimethylacetamide for 30 min before transferring into the de-Boc intermediate above in 1 mL of <i>N</i>,<i>N</i>-dimethylacetamide. The reaction mixture was stirred overnight, then subjected to normal EtOAc/H<sub>2</sub>O workup. After solvent removal, the resulting solid was filtered and washed with acetonitrile, giving 36 mg of the desired product as a pale white solid (62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H), 8.22 (d, 1H, <i>J</i> = 6.4 Hz), 7.52 (d, 1H, <i>J</i> = 6.4 Hz), 7.44 (t, 1H, <i>J</i> = 7.2 Hz), 7.36 (s, 1H), 6.11 (d, 1H, <i>J</i> = 1.2 Hz), 4.06 (t, 4H, <i>J</i> = 4.4 Hz), 3.89 (t, 4H, <i>J</i> = 5.2 Hz), 3.79 (s, 2H), 3.63 (br t, <i>J</i> = 4.4 Hz), 3.53 (br t, <i>J</i> = 4.4 Hz), 2.76 (t, 2H, <i>J</i> = 6.4 Hz), 2.59 (t, 2H, <i>J</i> = 6.4 Hz), 2.48 (m, 4H), 2.11 (d, 3H, <i>J</i> = 1.2 (Hz), 1.84 (d, 3H, <i>J</i> = 1.2 Hz) ppm. <sup>13</sup>C NMR (100 Hz, CDCl<sub>3</sub>): δ 199.5, 170.34, 162.5, 160.4, 158.1, 155.6, 149.1, 140.9, 136.5, 132.0, 126.4, 123.8, 123.7, 121.9, 121.6, 113.1, 111.5, 66.8, 57.4, 53.4, 52.9, 52.7, 46.4, 45.1, 41.6, 38.6, 30.9, 27.7, 26.9, 20.8 ppm. MS: <i>m</i>/<i>z</i> 574.2 (M + H). HRMS calcd for C<sub>30</sub>H<sub>37</sub>N<sub>7</sub>O<sub>3</sub>S 574.2600, found 574.2634.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-(Diethoxyphosphoryl)-4-oxopentanoic Acid (<b>4</b>)</h3><div class="NLM_p last">To a solution of diethyl methylphosphonate (0.76g, 5.0 mmol) in 20 mL of THF at −78 °C was added <i>n</i>-BuLi (2.5 N in hexane, 5.0 mmol) slowly. The reaction mixture was stirred at −78 °C for 1 h. Succinic anhydride (0.50 g 5.0 mmol) in 5.0 mL of anhydrous THF was introduced slowly into the mixture at −78 °C. The reaction mixture was stirred for 1 h at −78 °C. Then 1 N HCl (5.0 mL) aqueous solution was added and the mixture was warmed to room temperature. The THF was then removed under vacuum, and the remaining aqueous residue was extracted with dichloromethane (3 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent was removed. The residue was purified by chromatography on silica gel (eluent, EtOAc/MeOH 20:1) to provide the acid <b>4</b>. MS: <i>m</i>/<i>z</i> 253.1 (M + H); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.15 (4H, m), 3.18 (1H, s), 3.13 (1H, s), 2.95 (2H, t, <i>J</i> = 6.4 Hz), 2.63 (2H, t, <i>J</i> = 6.4 Hz), 1.33 (6H, m) ppm.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl 4-((2-(3-Hydroxyphenyl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazine-1-carboxylate (<b>5</b>)</h3><div class="NLM_p last">To a mixture of chloropyrimidine <b>1</b> (305 mg, 0.67 mmol), 3-hydroxyphenylboronic acid (139 mg, 1.0 mmol), and sodium carbonate (214 mg, 2 mmoL) in degassed toluene/ethanol/water (6 mL/3.6 mL/1.8 mL) was added tetrakis(triphenylphosphine)palladium (51 mg, 0.067 mmol). The reaction mixture was heated to 120 °C for 1 h under nitrogen, and the solvent was then removed under reduced pressure. The residue was subject to a quick aqueous EtOAc/water workup and purified by chromatography on silica gel (EtOAc/heptane v/v 1/1), giving 238 mg of yellow foamy solid as the title compound (69%). MS: <i>m</i>/<i>z</i> 512.3 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.49 (s, 1H), 7.87–7.81 (m, 2H), 7.38 (s, 1H), 7.26 (t, <i>J =</i> 8.11 Hz, 1H), 6.87–6.83 (m, 1H), 4.00–3.93 (m, 4H), 3.87 (s, 2H), 3.84–3.77 (m, 4H), 3.39–3.33 (m, 4H), 2.44 (s, 4H), 1.39 (s, 9H) ppm. <sup>13</sup>C NMR (100 Hz, CDCl<sub>3</sub>): δ 159.8, 158.9, 157.6, 156.5, 154.7, 149.7, 139.2, 129.5, 123.0, 120.1, 117.6, 115.0, 113.0, 79.9, 66.7, 57.5, 52.8, 46.3, 28.4 ppm. HRMS calcd for C<sub>26</sub>H<sub>34</sub>N<sub>5</sub>O<sub>4</sub>S 512.2331, found 512.2332 (M + H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Diethyl (5-(4-((2-(3-Hydroxyphenyl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazin-1-yl)-2,5-dioxopentyl)phosphonate (<b>6</b>)</h3><div class="NLM_p">Boc-piperazine <b>5</b> (360 mg, 0.7 mmol) was dissolved in 3 mL of 4 N HCl dioxane solution and dichloromethane (5 mL), and the reaction was continued for 3 h at room temperature. After removal of solvents, a white solid (350 mg) was obtained and used directly for the next step. MS: <i>m</i>/<i>z</i> 412.1 (M + H).</div><div class="NLM_p last">Phosphonate <b>4</b> (750 μL, 0.25 M acetonitrile solution, 187 μmol) was treated with carbonyldiimidazole (30 mg, 187 μmol) in 1 mL of <i>N</i>,<i>N</i>-dimethylacetamide for 30 min, followed by addition of the de-Boc intermediate obtained above (27.5 mg, 50 μmol). After being stirred for an additional 30 min, the reaction mixture was concentrated and the residue was purified by preparative HPLC, giving 15 mg of white powder after lyophilization (47%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.71 (t, <i>J =</i> 5.3 Hz, 2H), 7.23 (s, 1H), 7.18 (t, <i>J =</i> 7.9 Hz, 1H), 6.79 (ddd, <i>J =</i> 8.1, 2.5, 1.0 Hz, 1H), 4.09–4.00 (m, 4H), 3.98 (dd, <i>J =</i> 8.9, 4.4 Hz, 4H), 3.82 (s, 2H), 3.80–3.74 (m, 4H), 3.56–3.48 (m, 4H), 2.81 (t, <i>J =</i> 6.3 Hz, 2H), 2.60–2.49 (m, 4H), 2.49–2.42 (m, 2H), 1.23 (t, <i>J =</i> 7.1 Hz, 6H) ppm. <sup>13</sup>C NMR (100 Hz, CD<sub>3</sub>OD): δ 202.8 (d, <i>J</i> = 6.2 Hz), 172.2, 163.0, 161.4, 159.0, 158.7, 151.9, 140.8, 130.4, 123.6, 120.5, 118.3, 116.1, 114.2, 67.8, 64.1 (d, <i>J</i> = 6.4 Hz), 58.0, 53.9 (d, <i>J</i> = 25.6 Hz), 47.7, 46.6, 43.0, 39.8 (d, <i>J</i> = 2.4 Hz), 28.0, 16.6 (d, <i>J</i> = 6.2 Hz) ppm. MS: <i>m</i>/<i>z</i> 646.5 (M + H). HRMS calcd for C<sub>30</sub>H<sub>41</sub>N<sub>5</sub>O<sub>7</sub>S 646.2464, found 646.2466.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>E</i>)-<i>tert</i>-Butyl 4-(6-(4-((2-(3-Hydroxyphenyl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)piperazin-1-yl)-3,6-dioxohex-1-enyl)benzylcarbamate (<b>7</b>)</h3><div class="NLM_p last">A mixture of the phosphonate <b>5</b> (13 mg, 20 μmol), <i>tert</i>-butyl 4-formylbenzylcarbamate (10 mg, 40 μmol), potassium carbonate (40 mg) in 1 mL of <i>N</i>,<i>N</i>-dimethylacetamide, and 100 μL of water was heated at 70 °C for 4 h. After filtration, the reaction mixture was purified by preparative HPLC, giving 10 mg of desired enone <b>7</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.49 (s, 1H), 7.87–7.82 (m, 2H), 7.67 (d, <i>J =</i> 8.0 Hz, 2H), 7.58 (d, <i>J =</i> 16.3 Hz, 1H), 7.39 (s, 2H), 7.28 (dd, <i>J =</i> 8.3, 2.7 Hz, 3H), 6.89 (d, <i>J =</i> 16.2 Hz, 2H), 4.15 (d, <i>J =</i> 6.1 Hz, 2H), 3.96 (dd, <i>J =</i> 19.8, 14.9 Hz, 6H), 3.86–3.78 (m, 4H), 3.50 (d, <i>J =</i> 22.2 Hz, 4H), 3.32 (d, <i>J =</i> 9.5 Hz, 2H), 2.90 (d, <i>J =</i> 6.4 Hz, 2H), 2.62 (s, 2H), 2.44 (s, 2H), 1.37 (d, <i>J =</i> 24.0 Hz, 9H) ppm. <sup>13</sup>C NMR (100 Hz, MeOD): δ 199.3, 170.3, 162.2, 160.0, 157.8, 156.6, 156.0, 155.9, 149.2, 142.6, 139.7, 133.5, 129.5, 128.6, 127.9, 126.0, 123.4, 120.0, 117.4, 115.1, 113.1, 79.8, 66.8, 57.4, 53.0, 46.3, 45.3, 41.7, 35.4, 28.4, 27.1 ppm. MS: <i>m</i>/<i>z</i> 727.3 (M + H). HRMS calcd for C<sub>39</sub>H<sub>47</sub>N<sub>6</sub>O<sub>6</sub>S 727.3278, found 727.3276.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biotinylated Covalent Probe (<b>8</b>)</h3><div class="NLM_p last">To 7.5 mg of enone <b>7</b> in 1 mL of dichloromethane was added 1 mL of trifluoroacetic acid. After the mixture was stirred for 30 min, the solvent was removed under reduced pressure, giving de-Boc intermediate with <i>m</i>/<i>z</i> 627.3 (M + H). Then 1 mL of <i>N</i>,<i>N</i>-dimethylacetamide, 60 μL of DIPEA, and 9.0 mg of commercially available <i>N</i>-biotinyl-NH(PEG)<sub>2</sub>-COOH-DIPEA (20 atoms) (Novabiochem catalog no. 851029) were added, followed by 9 mg of HATU. After being stirred for an additional 30 min, the crude mixture was purified by preparative HPLC, giving 9 mg of desired compounds as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.76 (s, 1H), 7.67 (br t, 2H, <i>J</i> = 8.4 Hz), 7.60 (m, 2H), 7.44 (t, 1H, <i>J</i> = 8.0 Hz), 7.32 (d, 2H, <i>J</i> = 8.4 Hz), 7.13 (dd, 1H, <i>J</i> = 2.8, 16.4 Hz), 6.83 (d, 1H, <i>J</i> = 16.4 Hz), 4.66 (s, 2H), 4.48 (m, 2H), 4.38 (s, 2H), 4.30 (m, 4H), 3.92 (m, 4H), 3.83 (m, 2H), 3.62 (m, 4H), 3.57 (m, 4H), 3.50 (m, 4H), 3.15–3.30 (m, 8H), 3.70 (br t, 2H, <i>J</i> = 6.4 Hz), 2.90 (m, 2H), 2.67–2.76 (m, 4H), 2.15–2.30 (m, 8 H), 1.90 (m, 4H), 1.70–1.80 (m, 8H), 1.60 (m. 6H,), 1.40 (m, 4H) ppm. <sup>13</sup>C NMR (100 Hz, CD<sub>3</sub>OD): δ 201.3, 175.9, 175.3, 173.0, 166.0, 160.7, 160.3, 159.6, 158.1, 157.4, 152.2, 150.3, 144.0, 143.1, 134.8, 133.6, 131.6, 130.0, 129.7, 129.1, 126.8, 122.6, 122.2, 121.5, 120.3, 118.3, 116.4, 115.6, 71.5, 71.2, 69.9, 67.4, 63.4, 61.6, 57.0, 55.1, 53.2, 52.9, 43.8, 41.0, 40.8, 37.8, 36.8, 36.3, 36.2, 36.1, 30.4, 29.8, 29.5, 27.5, 26.9, 23.2 ppm. MS: <i>m</i>/<i>z</i> 1169.4 (M + H); 1167.6 (M-H). HRMS Calcd for C<sub>59</sub>H<sub>81</sub>N<sub>10</sub>O<sub>11</sub>S<sub>2</sub> 1169.5528, found 1169.5529.</div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Assays. Mass Spectrometry</h3><div class="NLM_p last">Mass spectrometry was used to confirm that <b>3</b> covalently bonds to PI3Kα but not to the other class I isoforms of PI3K. <b>3</b> was incubated with PI3Kα (Millipore, 14-602), PI3Kβ (Millipore, 14-603), PI3Kδ (Millipore, 14-604), PI3Kγ (BPS bioscience, BPS-40625) at a 10:1 compound-to-enzyme molar ratio at room temperature for 1 h. After the incubation, 10 mL of 0.2% TFA in water was added to each sample. Protein enrichment was achieved with a C4-packed ZipTip (Millipore), direct spotting onto a MALDI target plate, and combination with equal volume of sinapinic acid (10 mg/mL in 50% acetonitrile) as the desorption matrix. Once dry, the samples were analyzed on an AB Sciex 4800 MALDI TOF/TOF instrument.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Trypsin Digest</h3><div class="NLM_p last">After the reaction of PI3Kα with <b>3</b> as described above, the protein was separated by electrophoresis on a 4–12% Bis-Tris gel and stained with a Coomassie blue dye. The PI3Kα band was then excised from the gel and subjected to a standard in-gel trypsin digest. Peptide extract was then spotted directly on a MALDI target plate and combined with an equal volume of α-cyano-4-hydroxycinnamic acid (5 mg/mL in 80% acetonitrile) as the desorption matrix. Once dried, the spots were analyzed on an AB Sciex 4800 MALDI TOF/TOF instrument in both MS and MS/MS modes to confirm modification of the target amino acid for <b>3</b>. The targeted Cys862 in peptide NSHTIMQIQ<u class="uu">C</u>K was clearly modified.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> GSH Reactivity</h3><div class="NLM_p last">GSH reactivity was assessed by incubating 10 μM <b>3</b> at 37 °C in PBS at pH 7.4 with or without GSH (5 mM). At various designated time points, 50 μL of the reaction mixture was diluted with 50 μL of internal standard (1 μg/mL carbutamide in acetonitrile), injected onto a C8 column (Agilent Technologies, Zorbax, 3.5 μm, SB-C18, 2.1 mm × 30 mm), and analyzed with an AB Sciex QTrap 4000 mass spectrometer. Parent recovery was assessed and calculated as percent of the time zero value.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Plasma Protein Bonding</h3><div class="NLM_p last">Human plasma, obtained from Bioreclamation (Hicksville, NY), was subjected to albumin depletion using the Pierce Blue albumin removal kit (catalog no. 89845, Thermo Scientific, Rockford, IL) according to product procedures. The albumin-depleted plasma was then diluted to a final concentration of 1 mg/mL. It is important to note that albumin was depleted but not completely removed. A 10 mM DMSO stock of <b>3</b> was diluted 1:10 into 10 mg of the albumin-depleted human plasma. The reaction was carried out in a 96-well plate format in a 37 °C incubator. At the end of the incubation, 10 μL aliquots of the samples were diluted with 10 μL of 0.2% TFA and then pipetted with C4 ZipTips (Millipore) directly onto a MALDI target plate, using sinapinic acid as the desorption matrix (10 mg/mL in 0.1%TFA in acetonitrile/water 50:50 v/v) and ovalbumin as the internal standard. Samples were analyzed on an ABSciex 4800 MALDI TOF/TOF mass spectrometer.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> pAkt<sup>S473</sup> Immunoblot</h3><div class="NLM_p">SKOV3 cells were plated in SKOV3 growth medium (DMEM supplemented with 10% FBS and penicillin/streptomycin) at a density of 4 × 10<sup>5</sup> cells per well of 12-well plates. Twenty-four hours later the medium was removed and replaced with 1 mL of medium containing test compound in 0.1% DMSO and cells were returned to the incubator for 1 h. At the end of the hour, the medium was removed and the cells were washed with PBS, then lysed and scraped into 30 μL of cell extraction buffer (Biosource, Camarillo, CA) plus Complete protease inhibitor and PhosStop phosphatase inhibitor (Roche, Indianapolis, IN). Cell debris was spun down at 13000<i>g</i> for 1 min, and the supernatant was taken as the cell lysate. Protein concentration of the lysate was determined by BCA Assay (Pierce Biotechnology, Rockford, IL), and 50 μg of protein was loaded per well onto a NuPAGE Novex 4–12% Bis-Tris gel (Invitrogen, Carlsbad, CA) and then transferred to Immobilon PVDF-FL (Millipore, Billerica, MA).</div><div class="NLM_p">The blot was blocked in Odyssey blocking buffer (Li-Cor Biosciences, Lincoln, NE) for 1 h and then incubated overnight at 4 °C with mouse anti-Akt (no. 2920) and rabbit anti-phospho-Akt (Ser473) (no. 9271); Cell Signaling Technology, Beverley, MA) antibodies, both diluted 1:1000 in PBS/Odyssey Buffer (1:1) + 0.1% Tween-20. The blots were washed 3 times for 5 min each in PBS + 0.2% Tween-20 and then incubated for 1 h at room temperature with fluorescently labeled secondary antibodies (Li-Cor) diluted 1:10000 in PBS/Odyssey buffer (1:1) + 0.1% Tween-20.</div><div class="NLM_p last">The blots were washed 2 times for 5 min each in PBS + 0.2% Tween-20, once in distilled water, then scanned on an Odyssey machine (Li-Cor). Band intensity was determined using the Odyssey software, and the phopho-Akt signal was normalized to total Akt within samples, then expressed as a percentage of the untreated phospho-Akt signal.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Demonstration of Prolonged Duration of Inhibition</h3><div class="NLM_p">SKOV3 cells were plated in SKOV3 growth medium (DMEM supplemented with 10% FBS and pen/strep) at a density of 2.5 × 10<sup>4</sup> cells per well of Costar no. 3603 black 96-well clear flat-bottom plates. Plates were set up in quadruplicate with one plate each for the 0, 1, 6, and 24 h time points.</div><div class="NLM_p last">Twenty-four hours later the medium was removed and replaced with 100 μL of medium containing test compound or DMSO as a control and cells were returned to the incubator for 1 h. At the end of the hour, the medium was removed and the cells were washed 2 times with PBS. The PBS was removed from three of the plates, replaced with 100 μL of growth medium, and the plates were returned to the incubator. The fourth plate was taken as the “0”-hour time point and developed as described for in-cell Western or Western blot. Thirty minutes after the first wash, the medium was removed from the remaining plates, replaced with 100 μL of fresh growth medium, and then the plates were returned to the incubator. At 1 h after the first wash, one plate was taken as the 1 h time point and developed as an in-cell Western. The remaining two plates were washed two more times at 1 h intervals and developed as in-cell Western or Western blot at 6 and 24 h after the first wash.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In-Cell Western</h3><div class="NLM_p">Treated SKOV3 cells were washed once with PBS, then fixed for 20 min at room temperature in 4% formaldehyde in PBS. The formaldehyde was removed, and cells were washed 5 times for 5 min each with 100 μL of permeabilization buffer (PBS + 0.1% Triton X-100) at room temperature with gentle shaking. The last wash was removed and replaced with 150 μL of Odyssey blocking buffer (Li-Cor, Lincoln, NE) and incubated for 90 min at room temperature with gentle shaking.</div><div class="NLM_p">The blocking buffer was then replaced with 50 μL of primary antibody mix (rabbit anti-phospho-Akt(Ser473) at 1:100 (Cell Signaling Technology, Boston, MA) and mouse anti-tubulin at 1:5000 (Sigma Aldrich, St. Louis, MO) diluted in Odyssey blocking buffer) and incubated overnight at room temperature with gentle shaking.</div><div class="NLM_p">The next morning, the antibody mix was removed and the wells were washed 5 times for 5 min each with PBS + 0.1% Tween-20. The last wash was replaced with 50 μL of secondary antibody mix (goat anti-rabbit-IRDye-680 and goat anti-mouse-IRDye-800 (Li-Cor), both diluted 1:1000 in Odyssey blocking buffer + 0.2% Tween-20) and incubated for 1 h at room temperature with gentle shaking. The antibody mix was removed, and the wells were washed 5 times for 5 min each in PBS + 0.1% Tween-20, then 1 time with doubly distilled H<sub>2</sub>O.</div><div class="NLM_p last">The plates were scanned on an Odyssey machine (Li-Cor) with a 3 mm focus offset at an intensity of 8 in both channels, and the data were analyzed using the Odyssey software.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Cell Proliferation Assays and GI<sub>50</sub> Determinations in SKOV3 and MCF-7 Cells</h3><div class="NLM_p">SKOV3 cells or MCF-7 cells were plated in SKOV3 proliferation assay medium (DMEM supplemented with 5–10% FBS and pen/strep) at a density of 5000 cells in 180 μL volume per well in Costar no. 3610 white 96-well clear flat-bottom plates and incubated overnight in a humidified 37 °C incubator. A standard curve ranging from 10 000 to 50 000 cells was set up in a separate plate and allowed to adhere to the plate for 4–6 h, at which time the plate was developed using Cell Titer-Glo (Promega, Madison, WI) according to the manufacturer’s instructions.</div><div class="NLM_p">The next morning, 3-fold compound dilutions ranging from 10 000 to 40 nM were prepared in proliferation medium containing 1% DMSO. Then 20 μL of each dilution was added to the SKOV3 or MCF-7 cells plated the previous day, resulting in a dose–response curve from 1000 to 4 nM. The cells were incubated for 96 h and then developed with Cell Titer Glo.</div><div class="NLM_p last">The cell numbers at the end of the assay were determined using the standard curve generated at the start of the assay. Growth inhibition was calculated using the following formulas, and GI<sub>50</sub> values were determined by plotting the percent growth inhibition vs log of the compound concentration in GraphPad:<span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/jm-2012-008745_m001.gif" alt="" /></img></span>where <i>T</i> is the cell number at end of assay, <i>T</i><sub>0</sub> is the cell number at start of assay (5000), <i>C</i> is the mumber of cells in DMSO controls at end of assay, and<span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/jm-2012-008745_m002.gif" alt="" /></img></span></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Pharmacokinetic Study of <b>3</b></h3><div class="NLM_p">Fasted male C57BL/6 mice were dosed intraperitoneally (3 animals/time point) at 10 mg/kg using a dosing formulation consisting of 15% Solutol HS 15/5% DMSO/80% PBS. Blood samples (300 μL) were collected via terminal cardiac puncture and placed into chilled tubes containing EDTA as the anticoagulant. The samples were centrifuged at 4 °C at 13 000 rpm for 5 min, and plasma was collected and stored frozen until analysis. <b>3</b> was extracted from the plasma samples by protein precipitation, and the plasma concentration of <b>3</b> was assessed by LC–MS/MS using an API 4000 QTrap mass spectrometer. The bioanalytical method details are shown in <a class="ref internalNav" href="#notes-1" aria-label="Table S2">Table S2</a>, and the pharmacokinetic data are shown in Table S3 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p last">The calibration curve of <b>3</b> was constructed using standards ranging from 1 to 5000 ng/mL. The regression analysis of <b>3</b> was performed by plotting the peak area ratio of <b>3</b> over internal standard (<i>y</i>) against the <b>3</b> concentration (<i>x</i>) in ng/mL. Pharmacokinetic analysis was conducted using Analyst software (version 1.4.2; Life Technologies; Carlsbad, CA) for LC–MS/MS data management and WinNonlin (version 5.2; Pharsight Corporation; Mountain View, CA) for PK analysis. Mean plasma concentration values for each time point were used to generate time to achieve peak plasma concentration [<i>T</i><sub>max</sub> (h)], plasma terminal half-life [<i>t</i><sub>1/2</sub> (h)], peak plasma concentration [<i>C</i><sub>max</sub> (ng/mL)], and the area under the plasma concentration–time curve [AUC ((h·ng/mL)].</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vivo Pharmacodynamic Evaluation of the PI3Kα Covalent Inhibitor</h3><div class="NLM_p">Female nu/nu (<i>n</i> = 3/group) were administered compound (GDC-0941 or <b>3</b>) delivered ip at 100 mg/kg once daily for 5 consecutive days. After delivery of the last dose, spleens from treated animals were harvested at 1, 4, and 24 h time points. Spleens were immediately frozen in liquid nitrogen. Samples were stored at −80 °C until processing for homogenates. Homogenates were made by adding approximately 100 μL of spleen sample to a Precellys homogenizing tube (Precellys, Montigny, France) containing 300 μL of cell extraction buffer (Biosource, Camarillo, CA) plus Complete protease inhibitor and PhosStop phosphatase inhibitor (Roche, Indianapolis, IN) and kept on ice. The sample was homogenized in a Precellys 24 homogenizer for 15 s followed by centrifugation at 16000<i>g</i> for 20 min at 4 °C. The supernatant was moved to a new tube, and the protein concentration was determined by BCA Assay (Pierce Biotechnology, Rockford, IL).</div><div class="NLM_p last">An amount of 150 μg of protein sample was added to a 0.2 mL tube and the volume brought up to 100 μL with IP buffer from the protein A/G plate IP kit (Pierce Biotechnology, Rockford, IL). The covalent probe compound, <b>8</b>, was added at 1 μM, and the tube was incubated at room temperature with rocking for 1 h. Protein A/G coated wells from the protein A/G plate IP kit were washed 3× with 200 μL of IP buffer before coating with 4 μL of rabbit anti-p110α antibody (no. 4249, Cell Signaling Technology, Danvers, MA) plus 36 μL of IP buffer per well. After incubating at room temperature with shaking for 1 h, the wells were washed 5× with 200 μL of IP buffer and the protein samples, preincubated with <b>8</b>, were added to the wells. The wells were incubated overnight at 4 °C with shaking. The wells were then washed 5× with 200 μL of IP buffer. The immuoprecipitate was eluted from the plate with 40 μL of Pierce elution buffer (Pierce Biotechnology, Rockford, IL), and the eluate was moved to a 1.5 mL tube containing 4 μL of Pierce neutralization buffer (Pierce Biotechnology, Rockford, IL). The proteins were separated by electrophoresis and immunoblotted as described above. p110α was detected using an anti-p110α antibody (Epitomics, Burlingame, CA) diluted 1:2500 in PBS/Odyssey buffer (1:1) + 0.1% Tween-20. The blot was subsequently incubated with a fluorescently labeled secondary antibody, goat anti-rabbit-IRDye800 (Li-Cor) diluted 1:10000 in PBS/Odyssey buffer (1:1) + 0.1% Tween-20, and streptavidin-AlexaFluor-680 (Invitrogen) diluted 1:1000 to detect the biotinylated probe, The streptavidin signal, detecting covalent probe binding, was normalized to total p110α signal within samples, then expressed as a percentage of the vehicle treated samples.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Kinase Selectivity Panel</h3><div class="NLM_p"><b>3</b> was tested in a panel of 10 lipid kinases at the Reaction Biology Corporation (Malvern, PA). Briefly, compound was tested in a 10-concentration IC<sub>50</sub> curve with 3-fold serial dilution starting at 1 μM. Reactions were carried out at 10 μM ATP. An HTRF assay format was used for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ; ADP-GLO assay format was used for other kinases. The following substrates were used: for HTRF, phosphatidylinositol 4,5-bisphosphate; for SPHK1 and SPHK2, sphingosine; for other ADP-GLO enzymes, phosphatidylinositol.</div><div class="NLM_p last">For general kinase selectivity, <b>3</b> was run in a kinase selectivity panel at Reaction Biology Corporation (Malvern, PA) using HotSpot technology and radioisotope-based P81 filtration. <b>3</b> was dissolved in pure DMSO to the final 1 μM test concentration. Substrates for the various kinases tested against <b>3</b> were prepared fresh daily in reaction buffer. Any required cofactors were then added to the substrate solution followed by kinase addition and preincubated for 30 min at room temperature. <sup>33</sup>P-ATP (10 μM) was delivered into the reaction mixture to initiate the reaction, and reaction continued for 2 h at room temperature. The reaction was terminated, and any unreacted phosphate was washed away using 0.1% phosphoric acid prior to detection utilizing a proprietary technology (Reaction Biology Corp.; Malvern, PA, U.S.). The study was performed in duplicate, and 10 μM staurosporine, a nonselective, ATP-competitive kinase inhibitor, was used as the positive control.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Molecular Modeling of <b>3</b></h3><div class="NLM_p last">The binding mode of <b>3</b> to PI3Kα was obtained through molecular modeling to the X-ray structure of PI3Kα (p110α/p85α complex, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0">2RD0</a>). We initially superimposed the complex structures of PI3Kγ (GDC-0941, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>) and PI3Kα, then docked GDC-0941 into the PI3Kα protein. The key hinge binding interactions of the thienopyrimidine scaffold between PI3Kα and PI3Kγ are almost identical. We identified Cys862 as being unique to PI3Kα and determined it to be approximately 10 Å from the thienopyrimidine of GDC-0941. Through an iterative structure-based drug design process where we explored variations in linker length and electrophilic functionality, we identified <b>3</b>. The covalent bond between the thiol (Cys862) and <b>3</b> was formed in silico through a local minimization using CHARMM force field in Discovery Studio ( <cite>Discovery Studio Modeling Environment</cite>, release 2.1; Accelrys Software Inc.: San Diego, CA, <span class="NLM_year">2008</span>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/jm3008745">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Chemical structure of the covalent probe <b>8</b>; mass spectrometry on <b>3</b> with PI3K family members; specificity of <b>3</b> toward PI3Kα vs other kinases; lack of reactivity of <b>3</b> to nonspecific thiols including glutathione and plasma proteins; inhibition of PI3Kα signaling in SKOV3 cells by <b>3</b>; specificity of the covalent probe <b>8</b> for PI3Kα vs PI3Kβ in vitro; X-ray crystallography parameters of <b>3</b> complexed with PI3Kα. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3008745/suppl_file/jm3008745_si_001.pdf">jm3008745_si_001.pdf (599.17 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3008745" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mariana Nacht</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#325f5c53515a467251575e55575c571c515d5f"><span class="__cf_email__" data-cfemail="bad7d4dbd9d2cefad9dfd6dddfd4df94d9d5d7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixin Qiao</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael P. Sheets</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thia St. Martin</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Labenski</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hormoz Mazdiyasni</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell Karp</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhendong Zhu</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prasoon Chaturvedi</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepa Bhavsar</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deqiang Niu</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Westlin</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell C. Petter</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aravind Prasad Medikonda</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juswinder Singh</span> - <span class="hlFld-Affiliation affiliation">Celgene Avilomics Research, 45
Wiggins Avenue, Bedford, Massachusetts 01730, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are employees of Celgene (except D. Bhavsar, M. P. Sheets, W. Westlin).<br /></br><sup></sup>All authors except for D. Bhavsar, M. P. Sheets, and W. Westlin are shareholders in Celgene.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1250e2014-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Proteros Biostructures for assistance in solving the complex of PI3Kα with compound <b>3</b>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> Abbreviations Used</h2><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphate and tensin homologue</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneally</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrc2664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=19629070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=550-562&author=J.+A.+Engelman&title=Targeting+PI3K+signalling+in+cancer%3A+opportunities%2C+challenges+and+limitations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span></div><div class="casAuthors">Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-562</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are ample genetic and lab. studies that suggest the PI3K-Akt pathway is vital to the growth and survival of cancer cells.  Inhibitors targeting this pathway are entering the clinic at a rapid pace.  In this Review, the therapeutic potential of drugs targeting PI3K-Akt signaling for the treatment of cancer is discussed.  I focus on the advantages and drawbacks of different treatment strategies for targeting this pathway, the cancers that might respond best to these therapies and the challenges and limitations that confront their clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwdUnGEC20LVg90H21EOLACvtfcHk0ljX2MAKeDKzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D&md5=f0d4cc1fabf879e95f8b76e48cc9c1ad</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2664%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTargeting%2520PI3K%2520signalling%2520in%2520cancer%253A%2520opportunities%252C%2520challenges%2520and%2520limitations%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D550%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0ljX2MAKeDKzBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Stambolic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Pompa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtsos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovski, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1016%2FS0092-8674%2800%2981780-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=9778245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADyaK1cXmslWlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=29-39&author=V.+Stambolicauthor=A.+Suzukiauthor=J.+L.+de+la+Pompaauthor=G.+M.+Brothersauthor=C.+Mirtsosauthor=T.+Sasakiauthor=J.+Rulandauthor=J.+M.+Penningerauthor=D.+P.+Siderovskiauthor=T.+W.+Mak&title=Negative+regulation+of+PKB%2FAkt-dependent+cell+survival+by+the+tumor+suppressor+PTEN"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of PKB/Akt-Dependent cell survival by the tumor suppressor PTEN</span></div><div class="casAuthors">Stambolic, Vuk; Suzuki, Akira; De La Pompa, Jose Lois; Brothers, Greg M.; Mirtsos, Christine; Sasaki, Takehiko; Ruland, Jurgen; Penninger, Josef M.; Siderovski, David P.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PTEN is a tumor suppressor with sequence homol. to protein tyrosine phosphatases and the cytoskeletal protein tensin.  MPTEN-mutant mouse embryos display regions of increased proliferation.  In contrast, mPTEN-deficient immortalized mouse embryonic fibroblasts exhibit decreased sensitivity to cell death in response to a no. of apoptotic stimuli, accompanied by constitutively elevated activity and phosphorylation of protein kinase B/Akt, a crucial regulator of cell survival.  Expression of exogenous PTEN in mutant cells restores both their sensitivity to agonist-induced apoptosis and normal pattern of PKB/Akt phosphorylation.  Furthermore, PTEN neg. regulates intracellular levels of phosphatidylinositol (3,4,5)-trisphosphate in cells and dephosphorylates it in vitro.  Our results show that PTEN may exert its role as a tumor suppressor by neg. regulating the PI3'K/PKB/Akt signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeJuD58djBrVg90H21EOLACvtfcHk0lhmpPqsY76BTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslWlsr0%253D&md5=d0ffd63a69325f1296d08bdbc16c5f0f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981780-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981780-8%26sid%3Dliteratum%253Aachs%26aulast%3DStambolic%26aufirst%3DV.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPompa%26aufirst%3DJ.%2BL.%26aulast%3DBrothers%26aufirst%3DG.%2BM.%26aulast%3DMirtsos%26aufirst%3DC.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DSiderovski%26aufirst%3DD.%2BP.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DNegative%2520regulation%2520of%2520PKB%252FAkt-dependent%2520cell%2520survival%2520by%2520the%2520tumor%2520suppressor%2520PTEN%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D29%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Signaling by distinct classes of phosphoinositide 3-kinases</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1006%2Fexcr.1999.4701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=10579926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2it7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=239-254&author=B.+Vanhaesebroeckauthor=M.+D.+Waterfield&title=Signaling+by+distinct+classes+of+phosphoinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by Distinct Classes of Phosphoinositide 3-Kinases</span></div><div class="casAuthors">Vanhaesebroeck, B.; Waterfield, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-254</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 175 refs.  Many signaling pathways converge on and regulate phosphoinositide 3-kinase (PI3K) enzymes whose inositol lipid products are key mediators of intracellular signaling.  Different PI3K isoforms generate specific lipids that bind to FYVE and pleckstrin homol. (PH) domains in a variety of proteins, affecting their localization, conformation, and activities.  Here we review the activation mechanisms of the different types of PI3Ks and their downstream actions, with focus on the PI3Ks that are acutely triggered by extracellular stimulation.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyRLBP9HGmqbVg90H21EOLACvtfcHk0lhmpPqsY76BTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2it7Y%253D&md5=32dd3d70463fff2730d5bfdf4e1efc86</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4701%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DSignaling%2520by%2520distinct%2520classes%2520of%2520phosphoinositide%25203-kinases%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D239%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=3788-3793&author=J.+A.+Engelmanauthor=P.+A.+Janneauthor=C.+Mermelauthor=J.+Pearlbergauthor=T.+Mukoharaauthor=C.+Fleetauthor=K.+Cichowskiauthor=B.+E.+Johnsonauthor=L.+C.+Cantley&title=ErbB-3+mediates+phosphoinositide+3-kinase+activity+in+gefitinib-sensitive+non-small+cell+lung+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DPearlberg%26aufirst%3DJ.%26aulast%3DMukohara%26aufirst%3DT.%26aulast%3DFleet%26aufirst%3DC.%26aulast%3DCichowski%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DErbB-3%2520mediates%2520phosphoinositide%25203-kinase%2520activity%2520in%2520gefitinib-sensitive%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520lines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D3788%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabioullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponugoti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span> </span><span class="NLM_article-title">Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=287-290&author=J.+M.+Stommelauthor=A.+C.+Kimmelmanauthor=H.+Yingauthor=R.+Nabioullinauthor=A.+H.+Ponugotiauthor=R.+Wiedemeyerauthor=A.+H.+Steghauthor=J.+E.+Bradnerauthor=K.+L.+Ligonauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinho&title=Coactivation+of+receptor+tyrosine+kinases+affects+the+response+of+tumor+cells+to+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DNabioullin%26aufirst%3DR.%26aulast%3DPonugoti%26aufirst%3DA.%2BH.%26aulast%3DWiedemeyer%26aufirst%3DR.%26aulast%3DStegh%26aufirst%3DA.%2BH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DCoactivation%2520of%2520receptor%2520tyrosine%2520kinases%2520affects%2520the%2520response%2520of%2520tumor%2520cells%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D287%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas-Kogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dia, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chute, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1056%2FNEJMoa051918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16282176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2012-2024&author=I.+K.+Mellinghoffauthor=M.+Y.+Wangauthor=I.+Vivancoauthor=D.+A.+Haas-Koganauthor=S.+Zhuauthor=E.+Q.+Diaauthor=K.+V.+Luauthor=K.+Yoshimotoauthor=J.+H.+Huangauthor=D.+J.+Chuteauthor=B.+L.+Riggsauthor=S.+Horvathauthor=L.+M.+Liauauthor=W.+K.+Caveneeauthor=P.+N.+Raoauthor=R.+Beroukhimauthor=T.+C.+Peckauthor=J.+C.+Leeauthor=W.+R.+Sellersauthor=D.+Stokoeauthor=M.+Pradosauthor=T.+F.+Cloughesyauthor=C.+L.+Sawyersauthor=P.+S.+Mischel&title=Molecular+determinants+of+the+response+of+glioblastomas+to+EGFR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors</span></div><div class="casAuthors">Mellinghoff, Ingo K.; Wang, Maria Y.; Vivanco, Igor; Haas-Kogan, Daphne A.; Zhu, Shaojun; Dia, Ederlyn Q.; Lu, Kan V.; Yoshimoto, Koji; Huang, Julie H. Y.; Chute, Dennis J.; Riggs, Bridget L.; Horvath, Steve; Liau, Linda M.; Cavenee, Webster K.; Rao, P. Nagesh; Beroukhim, Rameen; Peck, Timothy C.; Lee, Jeffrey C.; Sellers, William R.; Stokoe, David; Prados, Michael; Cloughesy, Timothy F.; Sawyers, Charles L.; Mischel, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2012-2024</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is frequently amplified, overexpressed, or mutated in glioblastomas, but only 10 to 20 % of patients have a response to EGFR kinase inhibitors.  The mechanism of responsiveness of glioblastomas to these inhibitors is unknown.  We sequenced kinase domains in the EGFR and human EGFR type 2 (Her21neu) genes and analyzed the expression of EGFR, EGFR deletion mutantvariant III (EGFRvIII), and the tumor-suppressor protein PTEN in recurrent malignant gliomas from patients who had received EGFR kinase inhibitors.  We detd. the mol. correlates of clin. response, validated them in an independent data set, and identified effects of the mol. abnormalities in vitro.  Of 49 patients with recurrent malignant glioma who were treated with EGFR kinase inhibitors, 9 had tumor shrinkage of at least 25 %.  Pretreatment tissue was available for mol. anal. from 26 patients, 7 of whom had a response and 19 of whom had rapid progression during therapy.  No mutations in EGFR or Her2/neu kinase domains were detected in the tumors.  Coexpression of EGFRvIII and PTEN was significantly assocd. with a clin. response (P <0.001; odds ratio, 51; 95 % confidence interval, 4 to 669).  These findings were validated in 33 patients who received similar treatment for glioblastoma at a different institution (P = 0.001; odds ratio, 40; 95 % confidence interval, 3 to 468).  In vitro, coexpression of EGFRvIII and PTEN sensitized glioblastoma cells to erlotinib.  Coexpression of EGFRvIII and PTEN by glioblastoma cells is assocd. with responsiveness to EGFR kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUwTSK9-yL7Vg90H21EOLACvtfcHk0liWrFZWoV9x4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrtrrE&md5=e19cb1d6924c5019a7ed5d5f1ccdb6d0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051918%26sid%3Dliteratum%253Aachs%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DHaas-Kogan%26aufirst%3DD.%2BA.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DDia%26aufirst%3DE.%2BQ.%26aulast%3DLu%26aufirst%3DK.%2BV.%26aulast%3DYoshimoto%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DJ.%2BH.%26aulast%3DChute%26aufirst%3DD.%2BJ.%26aulast%3DRiggs%26aufirst%3DB.%2BL.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DRao%26aufirst%3DP.%2BN.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPeck%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DMolecular%2520determinants%2520of%2520the%2520response%2520of%2520glioblastomas%2520to%2520EGFR%2520kinase%2520inhibitors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2012%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0liWrFZWoV9x4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520mutations%253A%2520the%2520PI3K%2520pathway%2520as%2520an%2520integrator%2520of%2520multiple%2520inputs%2520during%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Class I PI3K in oncogenic cellular transformation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5486</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5486-5496&author=L.+Zhaoauthor=P.+K.+Vogt&title=Class+I+PI3K+in+oncogenic+cellular+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DClass%2520I%2520PI3K%2520in%2520oncogenic%2520cellular%2520transformation%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5486%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Karakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. H.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA oncogene in human cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fsj.bjc.6602970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16449998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=455-459&author=B.+Karakasauthor=K.+E.+Bachmanauthor=B.+H.+Park&title=Mutation+of+the+PIK3CA+oncogene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the PIK3CA oncogene in human cancers</span></div><div class="casAuthors">Karakas, B.; Bachman, K. E.; Park, B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is now well established that cancer is a genetic disease and that somatic mutations of oncogenes and tumor suppressor genes are the initiators of the carcinogenic process.  The phosphatidylinositol 3-kinase signaling pathway has previously been implicated in tumorigenesis, and evidence over the past year suggests a pivotal role for the phosphatidylinositol 3-kinase catalytic subunit, PIK3CA, in human cancers.  In this review, we analyze recent reports describing PIK3CA mutations in a variety of human malignancies, and discuss their possible implications for diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3GosToKQSIbVg90H21EOLACvtfcHk0liWrFZWoV9x4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D&md5=c109aaf6e660f6299d4db185be8a97ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602970%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BH.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520oncogene%2520in%2520human%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+mutations+identified+in+human+cancer+are+oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520mutations%2520identified%2520in%2520human%2520cancer%2520are%2520oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecil, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.2174%2F092986711796011229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21649578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2686-2714&author=S.+J.+Shuttleworthauthor=F.+A.+Silvaauthor=A.+R.+Cecilauthor=C.+D.+Tomassiauthor=T.+J.+Hillauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=P.+Workman&title=Progress+in+the+preclinical+discovery+and+clinical+development+of+class+I+and+dual+class+I%2FIV+phosphoinositide+3-kinase+%28PI3K%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span></div><div class="casAuthors">Shuttleworth, S. J.; Silva, F. A.; Cecil, A. R. L.; Tomassi, C. D.; Hill, T. J.; Raynaud, F. I.; Clarke, P. A.; Workman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2686-2714</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinases (PI3Ks) constitute an important family of lipid kinase enzymes that control a range of cellular processes through their regulation of a network of signal transduction pathways, and have emerged as important therapeutic targets in the context of cancer, inflammation and cardiovascular diseases.  Since the mid-late 1990s, considerable progress was made in the discovery and development of small mol. ATP-competitive PI3K inhibitors, a no. of which have entered early phase human trials over recent years from which key clin. results are now being disclosed.  This review summarizes progress made to date, primarily on the discovery and characterization of class I and dual class I/IV subtype inhibitors, together with advances that were made in translational and clin. research, notably in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibTyG_ua2WLVg90H21EOLACvtfcHk0lhhMXdNn8N11Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M&md5=baf93d773ce18eb70ebc5549c14f422c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986711796011229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011229%26sid%3Dliteratum%253Aachs%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26aulast%3DSilva%26aufirst%3DF.%2BA.%26aulast%3DCecil%26aufirst%3DA.%2BR.%26aulast%3DTomassi%26aufirst%3DC.%2BD.%26aulast%3DHill%26aufirst%3DT.%2BJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DProgress%2520in%2520the%2520preclinical%2520discovery%2520and%2520clinical%2520development%2520of%2520class%2520I%2520and%2520dual%2520class%2520I%252FIV%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2686%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI 3-kinase p110beta: a new target for antithrombotic therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI+3-kinase+p110beta%3A+a+new+target+for+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0lhhMXdNn8N11Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI%25203-kinase%2520p110beta%253A%2520a%2520new%2520target%2520for%2520antithrombotic%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">PI3K in lymphocyte development, differentiation and activation</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnri1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=12669022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=317-330&author=K.+Okkenhaugauthor=B.+Vanhaesebroeck&title=PI3K+in+lymphocyte+development%2C+differentiation+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K in lymphocyte development, differentiation and activation</span></div><div class="casAuthors">Okkenhaug, Klaus; Vanhaesebroeck, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3K) regulate numerous biol. processes, including cell growth, differentiation, survival, proliferation, migration, and metab.  In the immune system, impaired PI3K signaling leads to immunodeficiency, whereas unrestrained PI3K signaling contributes to autoimmunity and leukemia.  New insights into the role of PI3K in lymphocyte biol. have been derived from gene-targeting studies, which have identified the PI3K subunits that are involved in B-cell and T-cell signaling.  In particular, the catalytic subunit p110δ seems to be adapted to transmit antigen receptor signaling in B and T cells.  Addnl. recent work has provided new insights into the mol. interactions that lead to PI3K activation and the signaling pathways that are regulated by PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMNzLr_tCL7Vg90H21EOLACvtfcHk0liSjhG41wzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D&md5=97161849a1a965ce48f2641ec19c7941</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnri1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1056%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DPI3K%2520in%2520lymphocyte%2520development%252C%2520differentiation%2520and%2520activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kgamma inhibition: towards an “aspirin of the 21st century”?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-918&author=T.+Ruckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3Kgamma+inhibition%3A+towards+an+%E2%80%9Caspirin+of+the+21st+century%E2%80%9D%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3Kgamma%2520inhibition%253A%2520towards%2520an%2520%25E2%2580%259Caspirin%2520of%2520the%252021st%2520century%25E2%2580%259D%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0liSjhG41wzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluge, A. F.</span><span> </span><span class="NLM_article-title">Targeted covalent drugs of the kinase family</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1016%2Fj.cbpa.2010.06.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=20609616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=475-480&author=J.+Singhauthor=R.+C.+Petterauthor=A.+F.+Kluge&title=Targeted+covalent+drugs+of+the+kinase+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent drugs of the kinase family</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Kluge, Arthur F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-480</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past decade tremendous progress has been made toward a new class of therapeutics termed 'targeted covalent drugs', in which structure-based approaches are employed to create small mols. that inactivate their protein target through targeted covalent attachment to a specific cysteine.  In the kinase field, this approach is demonstrating promise in overcoming the potency, selectivity, and efficacy challenges currently faced by reversible kinase inhibitors, with several advancing into late stage clin. testing.  This design paradigm has been successfully applied to making drug candidates for epidermal growth factor receptor (EGFR), Her2, and Bruton's tyrosine kinase (Btk).  Here we review recent pre-clin. and clin. advances with targeted covalent kinase inhibitors, and the potential for broader application of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQb40Eok-vbVg90H21EOLACvtfcHk0liSjhG41wzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr8%253D&md5=ee3b8b9e0c6ec317f975a426cf08428f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.168%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26atitle%3DTargeted%2520covalent%2520drugs%2520of%2520the%2520kinase%2520family%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D475%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnchembio.492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21113170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=22-24&author=M.+Hagelauthor=D.+Niuauthor=M.+T.+Stauthor=M.+P.+Sheetsauthor=L.+Qiaoauthor=H.+Bernardauthor=R.+M.+Karpauthor=Z.+Zhuauthor=M.+T.+Labenskiauthor=P.+Chaturvediauthor=M.+Nachtauthor=W.+F.+Westlinauthor=R.+C.+Petterauthor=J.+Singh&title=Selective+irreversible+inhibition+of+a+protease+by+targeting+a+noncatalytic+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span></div><div class="casAuthors">Hagel, Margit; Niu, Deqiang; St. Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-24</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic app.  We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family.  We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcCQdERpWWLVg90H21EOLACvtfcHk0liSjhG41wzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M&md5=e2b523ebc4e1115beef32093003a10c9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.492%26sid%3Dliteratum%253Aachs%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DSt%26aufirst%3DM.%2BT.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DSelective%2520irreversible%2520inhibition%2520of%2520a%2520protease%2520by%2520targeting%2520a%2520noncatalytic%2520cysteine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D22%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.2174%2F092986711796011229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21649578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2686-2714&author=S.+J.+Shuttleworth&title=Progress+in+the+preclinical+discovery+and+clinical+development+of+class+I+and+dual+class+I%2FIV+phosphoinositide+3-kinase+%28PI3K%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span></div><div class="casAuthors">Shuttleworth, S. J.; Silva, F. A.; Cecil, A. R. L.; Tomassi, C. D.; Hill, T. J.; Raynaud, F. I.; Clarke, P. A.; Workman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2686-2714</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinases (PI3Ks) constitute an important family of lipid kinase enzymes that control a range of cellular processes through their regulation of a network of signal transduction pathways, and have emerged as important therapeutic targets in the context of cancer, inflammation and cardiovascular diseases.  Since the mid-late 1990s, considerable progress was made in the discovery and development of small mol. ATP-competitive PI3K inhibitors, a no. of which have entered early phase human trials over recent years from which key clin. results are now being disclosed.  This review summarizes progress made to date, primarily on the discovery and characterization of class I and dual class I/IV subtype inhibitors, together with advances that were made in translational and clin. research, notably in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibTyG_ua2WLVg90H21EOLACvtfcHk0liK5NJ2ju3DpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M&md5=baf93d773ce18eb70ebc5549c14f422c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986711796011229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011229%26sid%3Dliteratum%253Aachs%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520preclinical%2520discovery%2520and%2520clinical%2520development%2520of%2520class%2520I%2520and%2520dual%2520class%2520I%252FIV%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2686%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=L.+M.+Amzel&title=The+structure+of+a+human+p110alpha%2Fp85alpha+complex+elucidates+the+effects+of+oncogenic+PI3Kalpha+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520structure%2520of%2520a%2520human%2520p110alpha%252Fp85alpha%2520complex%2520elucidates%2520the%2520effects%2520of%2520oncogenic%2520PI3Kalpha%2520mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.+Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-t hieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-t+hieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0liwMNTZVHMb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-t%2520hieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ikediobi, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthorpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackenbury, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hills, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosmidou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mironenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tofts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widaa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span> </span><span class="NLM_article-title">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2606</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1158%2F1535-7163.MCT-06-0433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=17088437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2606-2612&author=O.+N.+Ikediobiauthor=H.+Daviesauthor=G.+Bignellauthor=S.+Edkinsauthor=C.+Stevensauthor=S.+O%E2%80%99Mearaauthor=T.+Santariusauthor=T.+Avisauthor=S.+Barthorpeauthor=L.+Brackenburyauthor=G.+Buckauthor=A.+Butlerauthor=J.+Clementsauthor=J.+Coleauthor=E.+Dicksauthor=S.+Forbesauthor=K.+Grayauthor=K.+Hallidayauthor=R.+Harrisonauthor=K.+Hillsauthor=J.+Hintonauthor=C.+Hunterauthor=A.+Jenkinsonauthor=D.+Jonesauthor=V.+Kosmidouauthor=R.+Luggauthor=A.+Menziesauthor=T.+Mironenkoauthor=A.+Parkerauthor=J.+Perryauthor=K.+Raineauthor=D.+Richardsonauthor=R.+Shepherdauthor=A.+Smallauthor=R.+Smithauthor=H.+Solomonauthor=P.+Stephensauthor=J.+Teagueauthor=C.+Toftsauthor=J.+Varianauthor=T.+Webbauthor=S.+Westauthor=S.+Widaaauthor=A.+Yatesauthor=W.+Reinholdauthor=J.+N.+Weinsteinauthor=M.+R.+Strattonauthor=P.+A.+Futrealauthor=R.+Wooster&title=Mutation+analysis+of+24+known+cancer+genes+in+the+NCI-60+cell+line+set"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span></div><div class="casAuthors">Ikediobi, Ogechi N.; Davies, Helen; Bignell, Graham; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Santarius, Thomas; Avis, Tim; Barthorpe, Syd; Brackenbury, Lisa; Buck, Gemma; Butler, Adam; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jonathan; Hunter, Chris; Jenkinson, Andy; Jones, David; Kosmidou, Vivienne; Lugg, Richard; Menzies, Andrew; Mironenko, Tatiana; Parker, Adrian; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alex; Smith, Raffaella; Solomon, Helen; Stephens, Philip; Teague, Jon; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Reinhold, William; Weinstein, John N.; Stratton, Michael R.; Futreal, P. Andrew; Wooster, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2606-2612</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource.  The NCI-60 has been characterized pharmacol. and at the mol. level more extensively than any other set of cell lines.  However, no systematic mutation anal. of genes causally implicated in oncogenesis has been reported.  This study reports the sequence anal. of 24 known cancer genes in the NCI-60 and an assessment of 4 of the 24 genes for homozygous deletions.  One hundred thirty-seven oncogenic mutations were identified in 14 (APC, BRAF, CDKN2, CTNNB1, HRAS, KRAS, NRAS, SMAD4, PIK3CA, PTEN, RB1, STK11, TP53, and VHL) of the 24 genes.  All lines have at least one mutation among the cancer genes examd., with most lines (73%) having more than one.  Identification of those cancer genes mutated in the NCI-60, in combination with pharmacol. and mol. profiles of the cells, will allow for more informed interpretation of anticancer agent screening and will enhance the use of the NCI-60 cell lines for molecularly targeted screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1IovOJtJWDbVg90H21EOLACvtfcHk0liwMNTZVHMb5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK&md5=f943d16d3e147357815de0ec3c29c30d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0433%26sid%3Dliteratum%253Aachs%26aulast%3DIkediobi%26aufirst%3DO.%2BN.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%26aulast%3DEdkins%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DS.%26aulast%3DSantarius%26aufirst%3DT.%26aulast%3DAvis%26aufirst%3DT.%26aulast%3DBarthorpe%26aufirst%3DS.%26aulast%3DBrackenbury%26aufirst%3DL.%26aulast%3DBuck%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DA.%26aulast%3DClements%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DDicks%26aufirst%3DE.%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DHalliday%26aufirst%3DK.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHills%26aufirst%3DK.%26aulast%3DHinton%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKosmidou%26aufirst%3DV.%26aulast%3DLugg%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DMironenko%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DRaine%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSolomon%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DTofts%26aufirst%3DC.%26aulast%3DVarian%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWidaa%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMutation%2520analysis%2520of%252024%2520known%2520cancer%2520genes%2520in%2520the%2520NCI-60%2520cell%2520line%2520set%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2606%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Krenske, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Transition states and energetics of nucleophilic additions of thiols to substituted alpha,beta-unsaturated ketones: substituent effects involve enone stabilization, product branching, and solvation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">5074</span><span class="NLM_x">–</span> <span class="NLM_lpage">5081</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo200761w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=5074-5081&author=E.+H.+Krenskeauthor=R.+C.+Petterauthor=Z.+Zhuauthor=K.+N.+Houk&title=Transition+states+and+energetics+of+nucleophilic+additions+of+thiols+to+substituted+alpha%2Cbeta-unsaturated+ketones%3A+substituent+effects+involve+enone+stabilization%2C+product+branching%2C+and+solvation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo200761w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo200761w%26sid%3Dliteratum%253Aachs%26aulast%3DKrenske%26aufirst%3DE.%2BH.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DTransition%2520states%2520and%2520energetics%2520of%2520nucleophilic%2520additions%2520of%2520thiols%2520to%2520substituted%2520alpha%252Cbeta-unsaturated%2520ketones%253A%2520substituent%2520effects%2520involve%2520enone%2520stabilization%252C%2520product%2520branching%252C%2520and%2520solvation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D5074%26epage%3D5081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lin Wei, Wuqiang Wen, Li Rao, Yunyuan Huang, Mengting Lei, Kai Liu, Saiya Hu, Rongrong Song, Yanliang Ren, <span class="NLM_string-name hlFld-ContribAuthor">Jian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (9)
                                     , 4388-4402. <a href="https://doi.org/10.1021/acs.jcim.9b01197" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b01197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b01197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b01197%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCov_FB3D%25253A%252BA%252BDe%252BNovo%252BCovalent%252BDrug%252BDesign%252BProtocol%252BIntegrating%252Bthe%252BBA-SAMP%252BStrategy%252Band%252BMachine-Learning-Based%252BSynthetic%252BTractability%252BEvaluation%26aulast%3DWei%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27122019%26date%3D09042020%26date%3D01042020%26volume%3D60%26issue%3D9%26spage%3D4388%26epage%3D4402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mami Sato, Hirokazu Fuchida, Naoya Shindo, Keiko Kuwata, Keisuke Tokunaga, Guo Xiao-Lin, Ryo Inamori, Keitaro Hosokawa, Kosuke Watari, Tomohiro Shibata, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo, Mayumi Ono, <span class="NLM_string-name hlFld-ContribAuthor">Akio Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1137-1144. <a href="https://doi.org/10.1021/acsmedchemlett.9b00574" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00574%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252BCovalent%252BTargeting%252Bof%252BMutated%252BEGFR%252528T790M%252529%252Bwith%252BChlorofluoroacetamide-Pyrimidines%26aulast%3DSato%26aufirst%3DMami%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04122019%26date%3D08042020%26date%3D10042020%26date%3D08042020%26volume%3D11%26issue%3D6%26spage%3D1137%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie
E. Garces, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4815-4850. <a href="https://doi.org/10.1021/acs.jmedchem.8b01492" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252B1%252BPI3K%252BClinical%252BCandidates%252Band%252BRecent%252BInhibitor%252BDesign%252BStrategies%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4815%26epage%3D4850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel E.  Dalton</span>, <span class="hlFld-ContribAuthor ">Lars  Dittus</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Máire A.  Convery</span>, <span class="hlFld-ContribAuthor ">Joao  Nunes</span>, <span class="hlFld-ContribAuthor ">Jacob T.  Bush</span>, <span class="hlFld-ContribAuthor ">John P.  Evans</span>, <span class="hlFld-ContribAuthor ">Thilo  Werner</span>, <span class="hlFld-ContribAuthor ">Marcus  Bantscheff</span>, <span class="hlFld-ContribAuthor ">John A.  Murphy</span>, and <span class="hlFld-ContribAuthor ">Sebastien  Campos</span>  . </span><span class="cited-content_cbyCitation_article-title">Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (3)
                                     , 932-939. <a href="https://doi.org/10.1021/jacs.7b08979" title="DOI URL">https://doi.org/10.1021/jacs.7b08979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.7b08979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.7b08979%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSelectively%252BTargeting%252Bthe%252BKinome-Conserved%252BLysine%252Bof%252BPI3K%2525CE%2525B4%252Bas%252Ba%252BGeneral%252BApproach%252Bto%252BCovalent%252BKinase%252BInhibition%26aulast%3DDalton%26aufirst%3DSamuel%2BE.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22082017%26date%3D09012018%26date%3D24012018%26date%3D12122017%26volume%3D140%26issue%3D3%26spage%3D932%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Lanxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, and <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4023-4035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDimorpholine%252BSubstituted%252BThienopyrimidines%252Bas%252BPotential%252BClass%252BI%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08032017%26date%3D24042017%26date%3D11052017%26date%3D14042017%26volume%3D60%26issue%3D9%26spage%3D4023%26epage%3D4035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Spencer  Bliven</span>, <span class="hlFld-ContribAuthor ">Lei  Xie</span>, and <span class="hlFld-ContribAuthor ">Philip E.  Bourne</span>  . </span><span class="cited-content_cbyCitation_article-title">Determining Cysteines Available for Covalent Inhibition Across the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2879-2889. <a href="https://doi.org/10.1021/acs.jmedchem.6b01815" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01815%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDetermining%252BCysteines%252BAvailable%252Bfor%252BCovalent%252BInhibition%252BAcross%252Bthe%252BHuman%252BKinome%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13122016%26date%3D04042017%26date%3D13042017%26date%3D22032017%26volume%3D60%26issue%3D7%26spage%3D2879%26epage%3D2889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Jackson</span>, <span class="hlFld-ContribAuthor ">John C.  Widen</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Harki</span>, and <span class="hlFld-ContribAuthor ">Kay M.  Brummond</span>  . </span><span class="cited-content_cbyCitation_article-title">Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 839-885. <a href="https://doi.org/10.1021/acs.jmedchem.6b00788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BModifiers%25253A%252BA%252BChemical%252BPerspective%252Bon%252Bthe%252BReactivity%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarbonyls%252Bwith%252BThiols%252Bvia%252BHetero-Michael%252BAddition%252BReactions%26aulast%3DJackson%26aufirst%3DPaul%2BA.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D25052016%26date%3D20122016%26date%3D09022017%26volume%3D60%26issue%3D3%26spage%3D839%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fleur M.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Jing  Ni</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Bethany  Tesar</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>, <span class="hlFld-ContribAuthor ">Nam Doo  Kim</span>, <span class="hlFld-ContribAuthor ">Xianming  Deng</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Brown</span>, <span class="hlFld-ContribAuthor ">Jean J.  Zhao</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 908-912. <a href="https://doi.org/10.1021/acsmedchemlett.6b00209" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00209%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B5%25252C11-Dihydro-6H-benzo%25255Be%25255Dpyrimido%25255B5%25252C4-b%25255D%25255B1%25252C4%25255Ddiazepin-6-ones%252Bas%252BSelective%252BPI3K-%2525CE%2525B4%25252F%2525CE%2525B3%252BInhibitors%26aulast%3DFerguson%26aufirst%3DFleur%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18052016%26date%3D02082016%26date%3D19082016%26date%3D13102016%26date%3D02082016%26volume%3D7%26issue%3D10%26spage%3D908%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Quan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-Jie  Luo</span>, <span class="hlFld-ContribAuthor ">Yan-Shi  Xiong</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, <span class="hlFld-ContribAuthor ">Zi-Jie  Long</span>, <span class="hlFld-ContribAuthor ">Xiao-Ju  Lai</span>, <span class="hlFld-ContribAuthor ">Hui-Xuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Jiang  Weng</span>, and <span class="hlFld-ContribAuthor ">Gui  Lu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7268-7274. <a href="https://doi.org/10.1021/acs.jmedchem.6b00235" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00235%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BSubstituted%252BPyrimidines%252Bas%252BPotential%252BPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252BInhibitors%26aulast%3DZhang%26aufirst%3DJi-Quan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16022016%26date%3D02082016%26date%3D11082016%26date%3D18072016%26volume%3D59%26issue%3D15%26spage%3D7268%26epage%3D7274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7611-7633. <a href="https://doi.org/10.1021/acs.jmedchem.5b00229" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStrategies%252Bfor%252Bthe%252BDiscovery%252Bof%252BTarget-Specific%252Bor%252BIsoform-Selective%252BModulators%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09022015%26date%3D01072015%26date%3D08102015%26date%3D18062015%26volume%3D58%26issue%3D19%26spage%3D7611%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona I.  McGonagle</span>, <span class="hlFld-ContribAuthor ">Helen F.  Sneddon</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molar Efficiency: A Useful Metric To Gauge Relative Reaction Efficiency in Discovery Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2014,</strong> <em>2 </em>
                                    (3)
                                     , 523-532. <a href="https://doi.org/10.1021/sc4004532" title="DOI URL">https://doi.org/10.1021/sc4004532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4004532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4004532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMolar%252BEfficiency%25253A%252BA%252BUseful%252BMetric%252BTo%252BGauge%252BRelative%252BReaction%252BEfficiency%252Bin%252BDiscovery%252BMedicinal%252BChemistry%26aulast%3DMcGonagle%26aufirst%3DFiona%2BI.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06112013%26date%3D28112013%26date%3D06122013%26date%3D03032014%26date%3D02122013%26volume%3D2%26issue%3D3%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanlong  Zhao</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingyi  Chen</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>, <span class="hlFld-ContribAuthor ">Yuefeng  Peng</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Chengliang  Guo</span>, <span class="hlFld-ContribAuthor ">Aiwu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jingmiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">QianCheng  Shen</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, and <span class="hlFld-ContribAuthor ">Jian  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (2)
                                     , 138-142. <a href="https://doi.org/10.1021/ml400378e" title="DOI URL">https://doi.org/10.1021/ml400378e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400378e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400378e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCrystal%252BStructures%252Bof%252BPI3K%2525CE%2525B1%252BComplexed%252Bwith%252BPI103%252Band%252BIts%252BDerivatives%25253A%252BNew%252BDirections%252Bfor%252BInhibitors%252BDesign%26aulast%3DZhao%26aufirst%3DYanlong%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D10122013%26date%3D11122013%26date%3D13022014%26date%3D10122013%26volume%3D5%26issue%3D2%26spage%3D138%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Shraddha  Parate</span>, <span class="hlFld-ContribAuthor ">Sanghwa  Yoon</span>, <span class="hlFld-ContribAuthor ">Gihwan  Lee</span>, <span class="hlFld-ContribAuthor ">Donghwan  Kim</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of ACK1 inhibitors as anticancer agents by using computer-aided drug designing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1235 </em>, 130200. <a href="https://doi.org/10.1016/j.molstruc.2021.130200" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIdentification%252Bof%252BACK1%252Binhibitors%252Bas%252Banticancer%252Bagents%252Bby%252Busing%252Bcomputer-aided%252Bdrug%252Bdesigning%26aulast%3DKumar%26aufirst%3DVikas%26date%3D2021%26volume%3D1235%26spage%3D130200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart  Vanhaesebroeck</span>, <span class="hlFld-ContribAuthor ">Matthew W. D.  Perry</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Brown</span>, <span class="hlFld-ContribAuthor ">Fabrice  André</span>, <span class="hlFld-ContribAuthor ">Klaus  Okkenhaug</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K inhibitors are finally coming of age. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>170 </em><a href="https://doi.org/10.1038/s41573-021-00209-1" title="DOI URL">https://doi.org/10.1038/s41573-021-00209-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-021-00209-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-021-00209-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPI3K%252Binhibitors%252Bare%252Bfinally%252Bcoming%252Bof%252Bage%26aulast%3DVanhaesebroeck%26aufirst%3DBart%26date%3D2021%26date%3D2021%26volume%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivy  Guan</span>, <span class="hlFld-ContribAuthor ">Kayla  Williams</span>, <span class="hlFld-ContribAuthor ">Jolyn  Pan</span>, <span class="hlFld-ContribAuthor ">Xuyu  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">New Cysteine Covalent Modification Strategies Enable Advancement of Proteome‐wide Selectivity of Kinase Modulators. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 949-963. <a href="https://doi.org/10.1002/ajoc.202100036" title="DOI URL">https://doi.org/10.1002/ajoc.202100036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100036%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNew%252BCysteine%252BCovalent%252BModification%252BStrategies%252BEnable%252BAdvancement%252Bof%252BProteome%2525E2%252580%252590wide%252BSelectivity%252Bof%252BKinase%252BModulators%26aulast%3DGuan%26aufirst%3DIvy%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D949%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sureshbabu Ram Kumar  Pandian</span>, <span class="hlFld-ContribAuthor ">Parasuraman  Pavadai</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Vellaisamy</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Ravishankar</span>, <span class="hlFld-ContribAuthor ">Ponnusamy  Palanisamy</span>, <span class="hlFld-ContribAuthor ">Lakshmi M.  Sundar</span>, <span class="hlFld-ContribAuthor ">Vivek  Chandramohan</span>, <span class="hlFld-ContribAuthor ">Murugesan  Sankaranarayanan</span>, <span class="hlFld-ContribAuthor ">Theivendren  Panneerselvam</span>, <span class="hlFld-ContribAuthor ">Selvaraj  Kunjiappan</span>. </span><span class="cited-content_cbyCitation_article-title">Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. </span><span class="cited-content_cbyCitation_journal-name">Naunyn-Schmiedeberg's Archives of Pharmacology</span><span> <strong>2021,</strong> <em>394 </em>
                                    (4)
                                     , 735-749. <a href="https://doi.org/10.1007/s00210-020-02015-9" title="DOI URL">https://doi.org/10.1007/s00210-020-02015-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00210-020-02015-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00210-020-02015-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Archives%2520of%2520Pharmacology%26atitle%3DFormulation%252Band%252Bevaluation%252Bof%252Brutin-loaded%252Bsolid%252Blipid%252Bnanoparticles%252Bfor%252Bthe%252Btreatment%252Bof%252Bbrain%252Btumor%26aulast%3DPandian%26aufirst%3DSureshbabu%2BRam%2BKumar%26date%3D2021%26date%3D2020%26volume%3D394%26issue%3D4%26spage%3D735%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weike  Liao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Yinliang  Qi</span>, <span class="hlFld-ContribAuthor ">Jiaan  Liu</span>, <span class="hlFld-ContribAuthor ">Juan  Xie</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Qiancheng  Lei</span>, <span class="hlFld-ContribAuthor ">Rui  Chen</span>, <span class="hlFld-ContribAuthor ">Ming  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Guowei  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112309. <a href="https://doi.org/10.1016/j.ejmech.2020.112309" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112309%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bnovel%252B2%25252C3%25252C4%25252C5-tetra-substituted%252Bthiophene%252Bderivatives%252Bas%252BPI3K%2525CE%2525B1%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivity%26aulast%3DLiao%26aufirst%3DWeike%26date%3D2020%26volume%3D197%26spage%3D112309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hyunbum  Jang</span>, <span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K inhibitors: review and new strategies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (23)
                                     , 5855-5865. <a href="https://doi.org/10.1039/D0SC01676D" title="DOI URL">https://doi.org/10.1039/D0SC01676D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC01676D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC01676D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DPI3K%252Binhibitors%25253A%252Breview%252Band%252Bnew%252Bstrategies%26aulast%3DZhang%26aufirst%3DMingzhen%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D23%26spage%3D5855%26epage%3D5865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yuqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Shouyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-target kinase drug design: Current strategies and future directions in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 112025. <a href="https://doi.org/10.1016/j.ejmech.2019.112025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.112025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.112025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.112025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-target%252Bkinase%252Bdrug%252Bdesign%25253A%252BCurrent%252Bstrategies%252Band%252Bfuture%252Bdirections%252Bin%252Bcancer%252Btherapy%26aulast%3DSun%26aufirst%3DDejuan%26date%3D2020%26volume%3D188%26spage%3D112025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 43-94. <a href="https://doi.org/10.1007/7355_2020_103" title="DOI URL">https://doi.org/10.1007/7355_2020_103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_103%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%25253A%252BAn%252BOverview%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D43%26epage%3D94%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob A.  McPhail</span>, <span class="hlFld-ContribAuthor ">John E.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 203-222. <a href="https://doi.org/10.1007/978-3-030-50621-6_9" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_9%26sid%3Dliteratum%253Aachs%26atitle%3DDrugging%252Bthe%252BPhosphoinositide%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B4-Kinase%252B%252528PI4K%252529%252BFamily%252Bof%252BEnzymes%252Bfor%252BTreatment%252Bof%252BCancer%25252C%252BImmune%252BDisorders%25252C%252Band%252BViral%25252FParasitic%252BInfections%26aulast%3DMcPhail%26aufirst%3DJacob%2BA.%26date%3D2020%26date%3D2020%26spage%3D203%26epage%3D222%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuyan  Yang</span>, <span class="hlFld-ContribAuthor ">Meng  Deng</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Ruan  Cong</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of thieno[3,2‐d]pyrimidine derivatives as potential simplified phosphatidylinositol 3‐kinase alpha inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>94 </em>
                                    (6)
                                     , 2013-2022. <a href="https://doi.org/10.1111/cbdd.13425" title="DOI URL">https://doi.org/10.1111/cbdd.13425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bthieno%25255B3%25252C2%2525E2%252580%252590d%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotential%252Bsimplified%252Bphosphatidylinositol%252B3%2525E2%252580%252590kinase%252Balpha%252Binhibitors%26aulast%3DYang%26aufirst%3DXiuyan%26date%3D2019%26date%3D2019%26volume%3D94%26issue%3D6%26spage%3D2013%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Avick Kumar  Ghosh</span>, <span class="hlFld-ContribAuthor ">Indranil  Samanta</span>, <span class="hlFld-ContribAuthor ">Anushree  Mondal</span>, <span class="hlFld-ContribAuthor ">Wenshe Ray  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Inhibition in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 889-906. <a href="https://doi.org/10.1002/cmdc.201900107" title="DOI URL">https://doi.org/10.1002/cmdc.201900107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900107%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCovalent%252BInhibition%252Bin%252BDrug%252BDiscovery%26aulast%3DGhosh%26aufirst%3DAvick%2BKumar%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D889%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoya  Shindo</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Fuchida</span>, <span class="hlFld-ContribAuthor ">Mami  Sato</span>, <span class="hlFld-ContribAuthor ">Kosuke  Watari</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Shibata</span>, <span class="hlFld-ContribAuthor ">Keiko  Kuwata</span>, <span class="hlFld-ContribAuthor ">Chizuru  Miura</span>, <span class="hlFld-ContribAuthor ">Kei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Yuji  Hatsuyama</span>, <span class="hlFld-ContribAuthor ">Keisuke  Tokunaga</span>, <span class="hlFld-ContribAuthor ">Seiichi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Satoshi  Morimoto</span>, <span class="hlFld-ContribAuthor ">Yoshito  Abe</span>, <span class="hlFld-ContribAuthor ">Mitsunori  Shiroishi</span>, <span class="hlFld-ContribAuthor ">Jose M. M.  Caaveiro</span>, <span class="hlFld-ContribAuthor ">Tadashi  Ueda</span>, <span class="hlFld-ContribAuthor ">Tomonori  Tamura</span>, <span class="hlFld-ContribAuthor ">Naoya  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Takaharu  Nakao</span>, <span class="hlFld-ContribAuthor ">Satoru  Koyanagi</span>, <span class="hlFld-ContribAuthor ">Shigehiro  Ohdo</span>, <span class="hlFld-ContribAuthor ">Yasuchika  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Itaru  Hamachi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Ono</span>, <span class="hlFld-ContribAuthor ">Akio  Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and reversible modification of kinase cysteines with chlorofluoroacetamides. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2019,</strong> <em>15 </em>
                                    (3)
                                     , 250-258. <a href="https://doi.org/10.1038/s41589-018-0204-3" title="DOI URL">https://doi.org/10.1038/s41589-018-0204-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-018-0204-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-018-0204-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DSelective%252Band%252Breversible%252Bmodification%252Bof%252Bkinase%252Bcysteines%252Bwith%252Bchlorofluoroacetamides%26aulast%3DShindo%26aufirst%3DNaoya%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D3%26spage%3D250%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Grace Qun  Gong</span>, <span class="hlFld-ContribAuthor ">Yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Woo-Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Christina Maree  Buchanan</span>, <span class="hlFld-ContribAuthor ">William Alexander  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon William  Rewcastle</span>, <span class="hlFld-ContribAuthor ">Jackie Diane  Kendall</span>, <span class="hlFld-ContribAuthor ">James Michael Jeremy  Dickson</span>, <span class="hlFld-ContribAuthor ">Jack Urquhart  Flanagan</span>, <span class="hlFld-ContribAuthor ">Peter Robin  Shepherd</span>, <span class="hlFld-ContribAuthor ">De-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (11)
                                     , 1816-1822. <a href="https://doi.org/10.1038/s41401-018-0057-z" title="DOI URL">https://doi.org/10.1038/s41401-018-0057-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-018-0057-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-018-0057-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DHigh-throughput%252Bscreening%252Bcampaigns%252Bagainst%252Ba%252BPI3K%2525CE%2525B1%252Bisoform%252Bbearing%252Bthe%252BH1047R%252Bmutation%252Bidentified%252Bpotential%252Binhibitors%252Bwith%252Bnovel%252Bscaffolds%26aulast%3DWang%26aufirst%3DJia%26date%3D2018%26date%3D2018%26volume%3D39%26issue%3D11%26spage%3D1816%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald  Nelson</span>, <span class="hlFld-ContribAuthor ">Taylor  Schronce</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Alanoud  Albugami</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>, <span class="hlFld-ContribAuthor ">Mark  Welker</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1628. <a href="https://doi.org/10.3390/molecules23071628" title="DOI URL">https://doi.org/10.3390/molecules23071628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071628%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BPI%252B3-Kinase%252BInhibition%252BActivity%252Bof%252BSome%252BNovel%252B2%25252C4%25252C6-Trisubstituted%252B1%25252C3%25252C5-Triazines%26aulast%3DNelson%26aufirst%3DRonald%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Das Cysteinom der Proteinkinasen als Zielstruktur in der Arzneistoffentwicklung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (16)
                                     , 4456-4470. <a href="https://doi.org/10.1002/ange.201707875" title="DOI URL">https://doi.org/10.1002/ange.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDas%252BCysteinom%252Bder%252BProteinkinasen%252Bals%252BZielstruktur%252Bin%252Bder%252BArzneistoffentwicklung%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D16%26spage%3D4456%26epage%3D4470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">The Cysteinome of Protein Kinases as a Target in Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (16)
                                     , 4372-4385. <a href="https://doi.org/10.1002/anie.201707875" title="DOI URL">https://doi.org/10.1002/anie.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252BCysteinome%252Bof%252BProtein%252BKinases%252Bas%252Ba%252BTarget%252Bin%252BDrug%252BDevelopment%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D16%26spage%3D4372%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-yang  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-wei  Liang</span>, <span class="hlFld-ContribAuthor ">Xin-yang  Li</span>, <span class="hlFld-ContribAuthor ">Kamara  Olounfeh</span>, <span class="hlFld-ContribAuthor ">Shi-long  Li</span>, <span class="hlFld-ContribAuthor ">Shan  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Fan-hao  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Study of Imidazolium Salt Derivatives as PIK3CA Inhibitors Using a Comprehensive in Silico Method. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (3)
                                     , 896. <a href="https://doi.org/10.3390/ijms19030896" title="DOI URL">https://doi.org/10.3390/ijms19030896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19030896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19030896%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStudy%252Bof%252BImidazolium%252BSalt%252BDerivatives%252Bas%252BPIK3CA%252BInhibitors%252BUsing%252Ba%252BComprehensive%252Bin%252BSilico%252BMethod%26aulast%3DWang%26aufirst%3DMing-yang%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D3%26spage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Vasta</span>, <span class="hlFld-ContribAuthor ">Cesear R.  Corona</span>, <span class="hlFld-ContribAuthor ">Jennifer  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Chad A.  Zimprich</span>, <span class="hlFld-ContribAuthor ">James R.  Hartnett</span>, <span class="hlFld-ContribAuthor ">Morgan R.  Ingold</span>, <span class="hlFld-ContribAuthor ">Kristopher  Zimmerman</span>, <span class="hlFld-ContribAuthor ">Thomas  Machleidt</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Kirkland</span>, <span class="hlFld-ContribAuthor ">Kristin G.  Huwiler</span>, <span class="hlFld-ContribAuthor ">Rachel Friedman  Ohana</span>, <span class="hlFld-ContribAuthor ">Michael  Slater</span>, <span class="hlFld-ContribAuthor ">Paul  Otto</span>, <span class="hlFld-ContribAuthor ">Mei  Cong</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Benedict-Tilman  Berger</span>, <span class="hlFld-ContribAuthor ">Thomas  Hanke</span>, <span class="hlFld-ContribAuthor ">Carina  Glas</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">Kilian V.M.  Huber</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Willson</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Poncho L.  Meisenheimer</span>, <span class="hlFld-ContribAuthor ">Frank  Fan</span>, <span class="hlFld-ContribAuthor ">Keith V.  Wood</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Robers</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (2)
                                     , 206-214.e11. <a href="https://doi.org/10.1016/j.chembiol.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DQuantitative%25252C%252BWide-Spectrum%252BKinase%252BProfiling%252Bin%252BLive%252BCells%252Bfor%252BAssessing%252Bthe%252BEffect%252Bof%252BCellular%252BATP%252Bon%252BTarget%252BEngagement%26aulast%3DVasta%26aufirst%3DJames%2BD.%26date%3D2018%26volume%3D25%26issue%3D2%26spage%3D206%26epage%3D214.e11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luhong  Wang</span>, <span class="hlFld-ContribAuthor ">Jingyuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Yao  Yao</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianbin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent binding design strategy: A prospective method for discovery of potent targeted anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 493-505. <a href="https://doi.org/10.1016/j.ejmech.2017.09.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Bbinding%252Bdesign%252Bstrategy%25253A%252BA%252Bprospective%252Bmethod%252Bfor%252Bdiscovery%252Bof%252Bpotent%252Btargeted%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DLuhong%26date%3D2017%26volume%3D142%26spage%3D493%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace Q.  Gong</span>, <span class="hlFld-ContribAuthor ">Jackie D.  Kendall</span>, <span class="hlFld-ContribAuthor ">James M.J.  Dickson</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>, <span class="hlFld-ContribAuthor ">Christina M.  Buchanan</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>. </span><span class="cited-content_cbyCitation_article-title">Combining properties of different classes of PI3Kα inhibitors to understand the molecular features that confer selectivity. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2017,</strong> <em>474 </em>
                                    (13)
                                     , 2261-2276. <a href="https://doi.org/10.1042/BCJ20161098" title="DOI URL">https://doi.org/10.1042/BCJ20161098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20161098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20161098%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DCombining%252Bproperties%252Bof%252Bdifferent%252Bclasses%252Bof%252BPI3K%2525CE%2525B1%252Binhibitors%252Bto%252Bunderstand%252Bthe%252Bmolecular%252Bfeatures%252Bthat%252Bconfer%252Bselectivity%26aulast%3DGong%26aufirst%3DGrace%2BQ.%26date%3D2017%26date%3D2017%26volume%3D474%26issue%3D13%26spage%3D2261%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 76-103. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12399-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12399-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12399-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12399-6%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%252Bfor%252BCancer%26aulast%3DOwens%26aufirst%3DTimothy%2BD.%26date%3D2017%26spage%3D76%26epage%3D103%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (43)
                                     , 13606-13619. <a href="https://doi.org/10.1002/ange.201601091" title="DOI URL">https://doi.org/10.1002/ange.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DZielgerichtete%252Bkovalente%252BInhibitoren%252Bf%2525C3%2525BCr%252Bdas%252BWirkstoffdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D43%26spage%3D13606%26epage%3D13619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibitors for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (43)
                                     , 13408-13421. <a href="https://doi.org/10.1002/anie.201601091" title="DOI URL">https://doi.org/10.1002/anie.201601091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201601091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201601091%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DTargeted%252BCovalent%252BInhibitors%252Bfor%252BDrug%252BDesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D43%26spage%3D13408%26epage%3D13421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Dubiella</span>, <span class="hlFld-ContribAuthor ">Regina  Baur</span>, <span class="hlFld-ContribAuthor ">Haissi  Cui</span>, <span class="hlFld-ContribAuthor ">Eva M.  Huber</span>, <span class="hlFld-ContribAuthor ">Michael  Groll</span>. </span><span class="cited-content_cbyCitation_article-title">Selektive Hemmung des Immunproteasoms durch strukturbasierte Wahl eines nichtkatalytischen Cysteins als Angriffspunkt. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (52)
                                     , 16116-16120. <a href="https://doi.org/10.1002/ange.201506631" title="DOI URL">https://doi.org/10.1002/ange.201506631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201506631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201506631%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSelektive%252BHemmung%252Bdes%252BImmunproteasoms%252Bdurch%252Bstrukturbasierte%252BWahl%252Beines%252Bnichtkatalytischen%252BCysteins%252Bals%252BAngriffspunkt%26aulast%3DDubiella%26aufirst%3DChristian%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D52%26spage%3D16116%26epage%3D16120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Dubiella</span>, <span class="hlFld-ContribAuthor ">Regina  Baur</span>, <span class="hlFld-ContribAuthor ">Haissi  Cui</span>, <span class="hlFld-ContribAuthor ">Eva M.  Huber</span>, <span class="hlFld-ContribAuthor ">Michael  Groll</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Inhibition of the Immunoproteasome by Structure-Based Targeting of a Non-catalytic Cysteine. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (52)
                                     , 15888-15891. <a href="https://doi.org/10.1002/anie.201506631" title="DOI URL">https://doi.org/10.1002/anie.201506631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201506631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201506631%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSelective%252BInhibition%252Bof%252Bthe%252BImmunoproteasome%252Bby%252BStructure-Based%252BTargeting%252Bof%252Ba%252BNon-catalytic%252BCysteine%26aulast%3DDubiella%26aufirst%3DChristian%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D52%26spage%3D15888%26epage%3D15891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, <span class="hlFld-ContribAuthor ">Elisa  Ciraolo</span>, <span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Jean  Margaria</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sorba</span>, <span class="hlFld-ContribAuthor ">Emilio  Hirsch</span>, <span class="hlFld-ContribAuthor ">Gian  Tron</span>. </span><span class="cited-content_cbyCitation_article-title">The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (9)
                                     , 17275-17287. <a href="https://doi.org/10.3390/molecules200917275" title="DOI URL">https://doi.org/10.3390/molecules200917275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200917275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200917275%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BGuareschi%252BPyridine%252BScaffold%252Bas%252Ba%252BValuable%252BPlatform%252Bfor%252Bthe%252BIdentification%252Bof%252BSelective%252BPI3K%252BInhibitors%26aulast%3DGalli%26aufirst%3DUbaldina%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D9%26spage%3D17275%26epage%3D17287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dima A.  Sabbah</span>, <span class="hlFld-ContribAuthor ">Musaab  Saada</span>, <span class="hlFld-ContribAuthor ">Reema Abu  Khalaf</span>, <span class="hlFld-ContribAuthor ">Sanaa  Bardaweel</span>, <span class="hlFld-ContribAuthor ">Kamal  Sweidan</span>, <span class="hlFld-ContribAuthor ">Tariq  Al-Qirim</span>, <span class="hlFld-ContribAuthor ">Amani  Al-Zughier</span>, <span class="hlFld-ContribAuthor ">Heba Abdel  Halim</span>, <span class="hlFld-ContribAuthor ">Ghassan Abu  Sheikha</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (16)
                                     , 3120-3124. <a href="https://doi.org/10.1016/j.bmcl.2015.06.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMolecular%252Bmodeling%252Bbased%252Bapproach%25252C%252Bsynthesis%25252C%252Band%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252Bbenzoin%252Bderivatives%252Btargeting%252Bphosphoinostide%252B3-kinase%252B%252528PI3K%2525CE%2525B1%252529%26aulast%3DSabbah%26aufirst%3DDima%2BA.%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3120%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>, <span class="hlFld-ContribAuthor ">Chung-Jung  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">The Design of Covalent Allosteric Drugs. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 249-267. <a href="https://doi.org/10.1146/annurev-pharmtox-010814-124401" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010814-124401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010814-124401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010814-124401%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DThe%252BDesign%252Bof%252BCovalent%252BAllosteric%252BDrugs%26aulast%3DNussinov%26aufirst%3DRuth%26date%3D2015%26volume%3D55%26issue%3D1%26spage%3D249%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shao  Sha</span>, <span class="hlFld-ContribAuthor ">Hong-Wei  Han</span>, <span class="hlFld-ContribAuthor ">Fei  Gao</span>, <span class="hlFld-ContribAuthor ">Tian-Bao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Chi  Xu</span>, <span class="hlFld-ContribAuthor ">Wei-Qing  Zhong</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of fluoroquinolone derivatives as potent, selective inhibitors of PI3Kγ. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 2029-2035. <a href="https://doi.org/10.1039/C5MD00364D" title="DOI URL">https://doi.org/10.1039/C5MD00364D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00364D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00364D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bfluoroquinolone%252Bderivatives%252Bas%252Bpotent%25252C%252Bselective%252Binhibitors%252Bof%252BPI3K%2525CE%2525B3%26aulast%3DSha%26aufirst%3DShao%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D2029%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Simon  Bergqvist</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Falk</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>. </span><span class="cited-content_cbyCitation_article-title">Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2014,</strong> <em>23 </em>
                                    (10)
                                     , 1332-1340. <a href="https://doi.org/10.1002/pro.2517" title="DOI URL">https://doi.org/10.1002/pro.2517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.2517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.2517%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DEngineering%252Bof%252Ban%252Bisolated%252Bp110%2525CE%2525B1%252Bsubunit%252Bof%252BPI3K%2525CE%2525B1%252Bpermits%252Bcrystallization%252Band%252Bprovides%252Ba%252Bplatform%252Bfor%252Bstructure-based%252Bdrug%252Bdesign%26aulast%3DChen%26aufirst%3DPing%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D10%26spage%3D1332%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle S.  Miller</span>, <span class="hlFld-ContribAuthor ">Oleg  Schmidt-Kittler</span>, <span class="hlFld-ContribAuthor ">David M.  Bolduc</span>, <span class="hlFld-ContribAuthor ">Evan T.  Brower</span>, <span class="hlFld-ContribAuthor ">Daniele  Chaves-Moreira</span>, <span class="hlFld-ContribAuthor ">Marc  Allaire</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Kinzler</span>, <span class="hlFld-ContribAuthor ">Ian G.  Jennings</span>, <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>, <span class="hlFld-ContribAuthor ">Philip A.  Cole</span>, <span class="hlFld-ContribAuthor ">L. Mario  Amzel</span>, <span class="hlFld-ContribAuthor ">Bert  Vogelstein</span>, <span class="hlFld-ContribAuthor ">Sandra B.  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of nSH2 regulation and lipid binding in PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2014,</strong> <em>5 </em>
                                    (14)
                                     , 5198-5208. <a href="https://doi.org/10.18632/oncotarget.2263" title="DOI URL">https://doi.org/10.18632/oncotarget.2263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2263%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DStructural%252Bbasis%252Bof%252BnSH2%252Bregulation%252Band%252Blipid%252Bbinding%252Bin%252BPI3K%2525CE%2525B1%26aulast%3DMiller%26aufirst%3DMichelle%2BS.%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D14%26spage%3D5198%26epage%3D5208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Daeil  Kwon</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and potent small-molecule inhibitors of PI3Ks. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (7)
                                     , 737-756. <a href="https://doi.org/10.4155/fmc.14.28" title="DOI URL">https://doi.org/10.4155/fmc.14.28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.28%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Band%252Bpotent%252Bsmall-molecule%252Binhibitors%252Bof%252BPI3Ks%26aulast%3DJeong%26aufirst%3DYujeong%26date%3D2014%26volume%3D6%26issue%3D7%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Heavey</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  O’Byrne</span>, <span class="hlFld-ContribAuthor ">Kathy  Gately</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2014,</strong> <em>40 </em>
                                    (3)
                                     , 445-456. <a href="https://doi.org/10.1016/j.ctrv.2013.08.006" title="DOI URL">https://doi.org/10.1016/j.ctrv.2013.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2013.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2013.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DStrategies%252Bfor%252Bco-targeting%252Bthe%252BPI3K%25252FAKT%25252FmTOR%252Bpathway%252Bin%252BNSCLC%26aulast%3DHeavey%26aufirst%3DSusan%26date%3D2014%26volume%3D40%26issue%3D3%26spage%3D445%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Fruman</span>, <span class="hlFld-ContribAuthor ">Christian  Rommel</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K and cancer: lessons, challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (2)
                                     , 140-156. <a href="https://doi.org/10.1038/nrd4204" title="DOI URL">https://doi.org/10.1038/nrd4204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4204%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPI3K%252Band%252Bcancer%25253A%252Blessons%25252C%252Bchallenges%252Band%252Bopportunities%26aulast%3DFruman%26aufirst%3DDavid%2BA.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D140%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, function and inhibition of the phosphoinositide 3-kinase p110α enzyme. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2014,</strong> <em>42 </em>
                                    (1)
                                     , 120-124. <a href="https://doi.org/10.1042/BST20130255" title="DOI URL">https://doi.org/10.1042/BST20130255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20130255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20130255%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DStructure%25252C%252Bfunction%252Band%252Binhibition%252Bof%252Bthe%252Bphosphoinositide%252B3-kinase%252Bp110%2525CE%2525B1%252Benzyme%26aulast%3DFlanagan%26aufirst%3DJack%25C2%25A0U.%26date%3D2014%26date%3D2014%26volume%3D42%26issue%3D1%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Mah</span>, <span class="hlFld-ContribAuthor ">Jason R.  Thomas</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery considerations in the development of covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 33-39. <a href="https://doi.org/10.1016/j.bmcl.2013.10.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDrug%252Bdiscovery%252Bconsiderations%252Bin%252Bthe%252Bdevelopment%252Bof%252Bcovalent%252Binhibitors%26aulast%3DMah%26aufirst%3DRobert%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 991-1012. <a href="https://doi.org/10.1517/17460441.2013.800479" title="DOI URL">https://doi.org/10.1517/17460441.2013.800479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.800479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.800479%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFurthering%252Bthe%252Bdesign%252Band%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252BATP-competitive%252BmTOR%252Binhibitors%252Bas%252Ban%252Beffective%252Bcancer%252Btreatment%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D991%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.  Lucas</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Targets for the Treatment of Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 149-167. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00011-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00011-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00011-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00011-9%26sid%3Dliteratum%253Aachs%26atitle%3DEmerging%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DLucas%26aufirst%3DMatthew%2BC.%26date%3D2013%26spage%3D149%26epage%3D167%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding site sequence and structure of PI3Kα complexed with compound <b>3</b>. (a) Binding site composition of class 1 PI3K isoforms α, β, γ, and δ. (b) X-ray complex of <b>3</b> to PI3Kα. The protein backbone is shown as a cartoon. The structure of <b>3</b> is shown as a stick representation, and the binding site residues are shown as lines. Hydrogen bonds between <b>3</b> and the protein are shown as dashed lines. C862 is highlighted, as well as D810, Y836, and V851 (hinge region) which are involved in hydrogen bonds with the inhibitor. (c) Overlay of <b>3</b>–PI3Kα (yellow) X-ray complex with X-ray complex of GDC-0941 bound to PI3Kγ (3DBS, Ggreen). (d) Electron density of <b>3</b> bound to PI3Kα. The ligand and neighboring protein side chains are shown as a stick model, colored according to the chemical atom type (<b>3</b> in cyan, human PI3K in gray, N in blue, O in red, and S in yellow). The ligand molecule is shown superimposed with the refined 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map contoured at 1.0.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. 2D chemical structure of (a) compound <b>3</b> and (b) GDC-0941.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) (1<i>H</i>-indazol-4-yl)boronic acid, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, DMA, microwave, 120 °C, 1 h, 73%; (b) HCl in dioxane, DCM–MeOH, 100%; (c) 6-methyl-4-oxohept-5-enoic acid, carbonyl diimidazole, DMA, rt, 45 min; then de-Boc intermediate, DIPEA, DMA, rt, overnight, 62%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) 3-hydroxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/ethanol/H<sub>2</sub>O, 120 °C, 1 h, 69%; (b) HCl in dioxane, DCM–MeOH, 100%; (c) compound <b>3</b>, carbonyldiimidazole, DMA, rt, 45 min; then de-Boc intermediate, DIPEA, DMA, rt, overnight, 47%; (d) K<sub>2</sub>CO<sub>3</sub>, DMA–H<sub>2</sub>O, 70 °C, 4 h; (e) CF<sub>3</sub>CO<sub>2</sub>H, dichloromethane; (f) <i>N</i>-biotinyl-NH-(PEG)<sub>2</sub>-COOH-DIPEA (20 atoms), HATU, DIPEA, DMA.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of p-Akt<sup>Ser473</sup> continues after removal of compound <b>3</b>. SKOV-3 cells were incubated with <b>3</b> or GDC-0941 (500 nM each) for 1 h. Medium was replaced with fresh compound-free medium at regular intervals, and cell lysates were prepared at the indicated times after compound removal. Cells were processed for in-cell Western analysis (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) to determine expression of P-Akt<sup>Ser473</sup>. Signaling returned immediately after removal of the reversible inhibitor, GDC-0941, but was inhibited >6 h after removal of <b>3</b>. Data shown are from duplicates. Experiment was performed at least 3 times: (∗∗) <i>p</i> < 0.001; (∗) <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/medium/jm-2012-008745_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>3</b> inhibited p-Akt<sup>Ser473</sup> in mouse spleens and bonds to PI3Kα in vivo. Compound <b>3</b> was delivered into the intraperitoneal cavity of nude mice at 100 mg/kg once a day for 5 consecutive days (<i>n</i> = 3 mice per group). Spleens were harvested from the mice at the indicated times after the last dose (1–24 h) and interrogated by immunoblot for P-Akt<sup>Ser473</sup> (a) or for PI3Kα occupancy (b) as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Inhibition of PI3K signaling was detected as a decrease in P-Akt<sup>Ser473</sup> at 1 and 4 h after last dose. Similarly, there was little/no free PI3Kα at 1 and 4 h after the last dose ((∗∗) <i>p</i> < 0.001). Protein resynthesis accounts for the return of free protein and signaling activity at 24 h ((∗∗) <i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-3/jm3008745/production/images/large/jm-2012-008745_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008745&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrc2664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=19629070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=550-562&author=J.+A.+Engelman&title=Targeting+PI3K+signalling+in+cancer%3A+opportunities%2C+challenges+and+limitations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span></div><div class="casAuthors">Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-562</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are ample genetic and lab. studies that suggest the PI3K-Akt pathway is vital to the growth and survival of cancer cells.  Inhibitors targeting this pathway are entering the clinic at a rapid pace.  In this Review, the therapeutic potential of drugs targeting PI3K-Akt signaling for the treatment of cancer is discussed.  I focus on the advantages and drawbacks of different treatment strategies for targeting this pathway, the cancers that might respond best to these therapies and the challenges and limitations that confront their clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwdUnGEC20LVg90H21EOLACvtfcHk0lgvwbasKcQvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D&md5=f0d4cc1fabf879e95f8b76e48cc9c1ad</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2664%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTargeting%2520PI3K%2520signalling%2520in%2520cancer%253A%2520opportunities%252C%2520challenges%2520and%2520limitations%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D550%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0ljJkWvSSKSI-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Stambolic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Pompa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtsos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penninger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovski, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1016%2FS0092-8674%2800%2981780-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=9778245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADyaK1cXmslWlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=29-39&author=V.+Stambolicauthor=A.+Suzukiauthor=J.+L.+de+la+Pompaauthor=G.+M.+Brothersauthor=C.+Mirtsosauthor=T.+Sasakiauthor=J.+Rulandauthor=J.+M.+Penningerauthor=D.+P.+Siderovskiauthor=T.+W.+Mak&title=Negative+regulation+of+PKB%2FAkt-dependent+cell+survival+by+the+tumor+suppressor+PTEN"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Negative regulation of PKB/Akt-Dependent cell survival by the tumor suppressor PTEN</span></div><div class="casAuthors">Stambolic, Vuk; Suzuki, Akira; De La Pompa, Jose Lois; Brothers, Greg M.; Mirtsos, Christine; Sasaki, Takehiko; Ruland, Jurgen; Penninger, Josef M.; Siderovski, David P.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PTEN is a tumor suppressor with sequence homol. to protein tyrosine phosphatases and the cytoskeletal protein tensin.  MPTEN-mutant mouse embryos display regions of increased proliferation.  In contrast, mPTEN-deficient immortalized mouse embryonic fibroblasts exhibit decreased sensitivity to cell death in response to a no. of apoptotic stimuli, accompanied by constitutively elevated activity and phosphorylation of protein kinase B/Akt, a crucial regulator of cell survival.  Expression of exogenous PTEN in mutant cells restores both their sensitivity to agonist-induced apoptosis and normal pattern of PKB/Akt phosphorylation.  Furthermore, PTEN neg. regulates intracellular levels of phosphatidylinositol (3,4,5)-trisphosphate in cells and dephosphorylates it in vitro.  Our results show that PTEN may exert its role as a tumor suppressor by neg. regulating the PI3'K/PKB/Akt signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeJuD58djBrVg90H21EOLACvtfcHk0ljJkWvSSKSI-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslWlsr0%253D&md5=d0ffd63a69325f1296d08bdbc16c5f0f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981780-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981780-8%26sid%3Dliteratum%253Aachs%26aulast%3DStambolic%26aufirst%3DV.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3Dde%2Bla%2BPompa%26aufirst%3DJ.%2BL.%26aulast%3DBrothers%26aufirst%3DG.%2BM.%26aulast%3DMirtsos%26aufirst%3DC.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DSiderovski%26aufirst%3DD.%2BP.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DNegative%2520regulation%2520of%2520PKB%252FAkt-dependent%2520cell%2520survival%2520by%2520the%2520tumor%2520suppressor%2520PTEN%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D29%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span> </span><span class="NLM_article-title">Signaling by distinct classes of phosphoinositide 3-kinases</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1006%2Fexcr.1999.4701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=10579926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2it7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=239-254&author=B.+Vanhaesebroeckauthor=M.+D.+Waterfield&title=Signaling+by+distinct+classes+of+phosphoinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by Distinct Classes of Phosphoinositide 3-Kinases</span></div><div class="casAuthors">Vanhaesebroeck, B.; Waterfield, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-254</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 175 refs.  Many signaling pathways converge on and regulate phosphoinositide 3-kinase (PI3K) enzymes whose inositol lipid products are key mediators of intracellular signaling.  Different PI3K isoforms generate specific lipids that bind to FYVE and pleckstrin homol. (PH) domains in a variety of proteins, affecting their localization, conformation, and activities.  Here we review the activation mechanisms of the different types of PI3Ks and their downstream actions, with focus on the PI3Ks that are acutely triggered by extracellular stimulation.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyRLBP9HGmqbVg90H21EOLACvtfcHk0ljJkWvSSKSI-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2it7Y%253D&md5=32dd3d70463fff2730d5bfdf4e1efc86</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4701%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DSignaling%2520by%2520distinct%2520classes%2520of%2520phosphoinositide%25203-kinases%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D239%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearlberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cichowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=3788-3793&author=J.+A.+Engelmanauthor=P.+A.+Janneauthor=C.+Mermelauthor=J.+Pearlbergauthor=T.+Mukoharaauthor=C.+Fleetauthor=K.+Cichowskiauthor=B.+E.+Johnsonauthor=L.+C.+Cantley&title=ErbB-3+mediates+phosphoinositide+3-kinase+activity+in+gefitinib-sensitive+non-small+cell+lung+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DPearlberg%26aufirst%3DJ.%26aulast%3DMukohara%26aufirst%3DT.%26aulast%3DFleet%26aufirst%3DC.%26aulast%3DCichowski%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DErbB-3%2520mediates%2520phosphoinositide%25203-kinase%2520activity%2520in%2520gefitinib-sensitive%2520non-small%2520cell%2520lung%2520cancer%2520cell%2520lines%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D3788%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Stommel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabioullin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponugoti, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedemeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegh, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span> </span><span class="NLM_article-title">Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=287-290&author=J.+M.+Stommelauthor=A.+C.+Kimmelmanauthor=H.+Yingauthor=R.+Nabioullinauthor=A.+H.+Ponugotiauthor=R.+Wiedemeyerauthor=A.+H.+Steghauthor=J.+E.+Bradnerauthor=K.+L.+Ligonauthor=C.+Brennanauthor=L.+Chinauthor=R.+A.+DePinho&title=Coactivation+of+receptor+tyrosine+kinases+affects+the+response+of+tumor+cells+to+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStommel%26aufirst%3DJ.%2BM.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DNabioullin%26aufirst%3DR.%26aulast%3DPonugoti%26aufirst%3DA.%2BH.%26aulast%3DWiedemeyer%26aufirst%3DR.%26aulast%3DStegh%26aufirst%3DA.%2BH.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DBrennan%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DCoactivation%2520of%2520receptor%2520tyrosine%2520kinases%2520affects%2520the%2520response%2520of%2520tumor%2520cells%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D287%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas-Kogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dia, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chute, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2012</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1056%2FNEJMoa051918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16282176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2012-2024&author=I.+K.+Mellinghoffauthor=M.+Y.+Wangauthor=I.+Vivancoauthor=D.+A.+Haas-Koganauthor=S.+Zhuauthor=E.+Q.+Diaauthor=K.+V.+Luauthor=K.+Yoshimotoauthor=J.+H.+Huangauthor=D.+J.+Chuteauthor=B.+L.+Riggsauthor=S.+Horvathauthor=L.+M.+Liauauthor=W.+K.+Caveneeauthor=P.+N.+Raoauthor=R.+Beroukhimauthor=T.+C.+Peckauthor=J.+C.+Leeauthor=W.+R.+Sellersauthor=D.+Stokoeauthor=M.+Pradosauthor=T.+F.+Cloughesyauthor=C.+L.+Sawyersauthor=P.+S.+Mischel&title=Molecular+determinants+of+the+response+of+glioblastomas+to+EGFR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors</span></div><div class="casAuthors">Mellinghoff, Ingo K.; Wang, Maria Y.; Vivanco, Igor; Haas-Kogan, Daphne A.; Zhu, Shaojun; Dia, Ederlyn Q.; Lu, Kan V.; Yoshimoto, Koji; Huang, Julie H. Y.; Chute, Dennis J.; Riggs, Bridget L.; Horvath, Steve; Liau, Linda M.; Cavenee, Webster K.; Rao, P. Nagesh; Beroukhim, Rameen; Peck, Timothy C.; Lee, Jeffrey C.; Sellers, William R.; Stokoe, David; Prados, Michael; Cloughesy, Timothy F.; Sawyers, Charles L.; Mischel, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2012-2024</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR) is frequently amplified, overexpressed, or mutated in glioblastomas, but only 10 to 20 % of patients have a response to EGFR kinase inhibitors.  The mechanism of responsiveness of glioblastomas to these inhibitors is unknown.  We sequenced kinase domains in the EGFR and human EGFR type 2 (Her21neu) genes and analyzed the expression of EGFR, EGFR deletion mutantvariant III (EGFRvIII), and the tumor-suppressor protein PTEN in recurrent malignant gliomas from patients who had received EGFR kinase inhibitors.  We detd. the mol. correlates of clin. response, validated them in an independent data set, and identified effects of the mol. abnormalities in vitro.  Of 49 patients with recurrent malignant glioma who were treated with EGFR kinase inhibitors, 9 had tumor shrinkage of at least 25 %.  Pretreatment tissue was available for mol. anal. from 26 patients, 7 of whom had a response and 19 of whom had rapid progression during therapy.  No mutations in EGFR or Her2/neu kinase domains were detected in the tumors.  Coexpression of EGFRvIII and PTEN was significantly assocd. with a clin. response (P <0.001; odds ratio, 51; 95 % confidence interval, 4 to 669).  These findings were validated in 33 patients who received similar treatment for glioblastoma at a different institution (P = 0.001; odds ratio, 40; 95 % confidence interval, 3 to 468).  In vitro, coexpression of EGFRvIII and PTEN sensitized glioblastoma cells to erlotinib.  Coexpression of EGFRvIII and PTEN by glioblastoma cells is assocd. with responsiveness to EGFR kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUwTSK9-yL7Vg90H21EOLACvtfcHk0limqDpn46efow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrtrrE&md5=e19cb1d6924c5019a7ed5d5f1ccdb6d0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051918%26sid%3Dliteratum%253Aachs%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DHaas-Kogan%26aufirst%3DD.%2BA.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DDia%26aufirst%3DE.%2BQ.%26aulast%3DLu%26aufirst%3DK.%2BV.%26aulast%3DYoshimoto%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DJ.%2BH.%26aulast%3DChute%26aufirst%3DD.%2BJ.%26aulast%3DRiggs%26aufirst%3DB.%2BL.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DRao%26aufirst%3DP.%2BN.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPeck%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DPrados%26aufirst%3DM.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DMolecular%2520determinants%2520of%2520the%2520response%2520of%2520glioblastomas%2520to%2520EGFR%2520kinase%2520inhibitors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2012%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0lgPOXPaU81G6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520mutations%253A%2520the%2520PI3K%2520pathway%2520as%2520an%2520integrator%2520of%2520multiple%2520inputs%2520during%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Class I PI3K in oncogenic cellular transformation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5486</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5486-5496&author=L.+Zhaoauthor=P.+K.+Vogt&title=Class+I+PI3K+in+oncogenic+cellular+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DClass%2520I%2520PI3K%2520in%2520oncogenic%2520cellular%2520transformation%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5486%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Karakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. H.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA oncogene in human cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fsj.bjc.6602970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=16449998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=455-459&author=B.+Karakasauthor=K.+E.+Bachmanauthor=B.+H.+Park&title=Mutation+of+the+PIK3CA+oncogene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the PIK3CA oncogene in human cancers</span></div><div class="casAuthors">Karakas, B.; Bachman, K. E.; Park, B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is now well established that cancer is a genetic disease and that somatic mutations of oncogenes and tumor suppressor genes are the initiators of the carcinogenic process.  The phosphatidylinositol 3-kinase signaling pathway has previously been implicated in tumorigenesis, and evidence over the past year suggests a pivotal role for the phosphatidylinositol 3-kinase catalytic subunit, PIK3CA, in human cancers.  In this review, we analyze recent reports describing PIK3CA mutations in a variety of human malignancies, and discuss their possible implications for diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3GosToKQSIbVg90H21EOLACvtfcHk0lgPOXPaU81G6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D&md5=c109aaf6e660f6299d4db185be8a97ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602970%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BH.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520oncogene%2520in%2520human%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+mutations+identified+in+human+cancer+are+oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520mutations%2520identified%2520in%2520human%2520cancer%2520are%2520oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecil, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassi, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.2174%2F092986711796011229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21649578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2686-2714&author=S.+J.+Shuttleworthauthor=F.+A.+Silvaauthor=A.+R.+Cecilauthor=C.+D.+Tomassiauthor=T.+J.+Hillauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=P.+Workman&title=Progress+in+the+preclinical+discovery+and+clinical+development+of+class+I+and+dual+class+I%2FIV+phosphoinositide+3-kinase+%28PI3K%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span></div><div class="casAuthors">Shuttleworth, S. J.; Silva, F. A.; Cecil, A. R. L.; Tomassi, C. D.; Hill, T. J.; Raynaud, F. I.; Clarke, P. A.; Workman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2686-2714</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinases (PI3Ks) constitute an important family of lipid kinase enzymes that control a range of cellular processes through their regulation of a network of signal transduction pathways, and have emerged as important therapeutic targets in the context of cancer, inflammation and cardiovascular diseases.  Since the mid-late 1990s, considerable progress was made in the discovery and development of small mol. ATP-competitive PI3K inhibitors, a no. of which have entered early phase human trials over recent years from which key clin. results are now being disclosed.  This review summarizes progress made to date, primarily on the discovery and characterization of class I and dual class I/IV subtype inhibitors, together with advances that were made in translational and clin. research, notably in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibTyG_ua2WLVg90H21EOLACvtfcHk0lgTybGs6ppC7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M&md5=baf93d773ce18eb70ebc5549c14f422c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986711796011229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011229%26sid%3Dliteratum%253Aachs%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26aulast%3DSilva%26aufirst%3DF.%2BA.%26aulast%3DCecil%26aufirst%3DA.%2BR.%26aulast%3DTomassi%26aufirst%3DC.%2BD.%26aulast%3DHill%26aufirst%3DT.%2BJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DProgress%2520in%2520the%2520preclinical%2520discovery%2520and%2520clinical%2520development%2520of%2520class%2520I%2520and%2520dual%2520class%2520I%252FIV%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2686%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI 3-kinase p110beta: a new target for antithrombotic therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI+3-kinase+p110beta%3A+a+new+target+for+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0lgTybGs6ppC7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI%25203-kinase%2520p110beta%253A%2520a%2520new%2520target%2520for%2520antithrombotic%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">PI3K in lymphocyte development, differentiation and activation</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnri1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=12669022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=317-330&author=K.+Okkenhaugauthor=B.+Vanhaesebroeck&title=PI3K+in+lymphocyte+development%2C+differentiation+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K in lymphocyte development, differentiation and activation</span></div><div class="casAuthors">Okkenhaug, Klaus; Vanhaesebroeck, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3K) regulate numerous biol. processes, including cell growth, differentiation, survival, proliferation, migration, and metab.  In the immune system, impaired PI3K signaling leads to immunodeficiency, whereas unrestrained PI3K signaling contributes to autoimmunity and leukemia.  New insights into the role of PI3K in lymphocyte biol. have been derived from gene-targeting studies, which have identified the PI3K subunits that are involved in B-cell and T-cell signaling.  In particular, the catalytic subunit p110δ seems to be adapted to transmit antigen receptor signaling in B and T cells.  Addnl. recent work has provided new insights into the mol. interactions that lead to PI3K activation and the signaling pathways that are regulated by PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMNzLr_tCL7Vg90H21EOLACvtfcHk0lgltTHvT2hMHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D&md5=97161849a1a965ce48f2641ec19c7941</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnri1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1056%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DPI3K%2520in%2520lymphocyte%2520development%252C%2520differentiation%2520and%2520activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kgamma inhibition: towards an “aspirin of the 21st century”?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-918&author=T.+Ruckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3Kgamma+inhibition%3A+towards+an+%E2%80%9Caspirin+of+the+21st+century%E2%80%9D%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3Kgamma%2520inhibition%253A%2520towards%2520an%2520%25E2%2580%259Caspirin%2520of%2520the%252021st%2520century%25E2%2580%259D%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lgUpwzTl61m_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluge, A. F.</span><span> </span><span class="NLM_article-title">Targeted covalent drugs of the kinase family</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1016%2Fj.cbpa.2010.06.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=20609616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=475-480&author=J.+Singhauthor=R.+C.+Petterauthor=A.+F.+Kluge&title=Targeted+covalent+drugs+of+the+kinase+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent drugs of the kinase family</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Kluge, Arthur F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">475-480</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the past decade tremendous progress has been made toward a new class of therapeutics termed 'targeted covalent drugs', in which structure-based approaches are employed to create small mols. that inactivate their protein target through targeted covalent attachment to a specific cysteine.  In the kinase field, this approach is demonstrating promise in overcoming the potency, selectivity, and efficacy challenges currently faced by reversible kinase inhibitors, with several advancing into late stage clin. testing.  This design paradigm has been successfully applied to making drug candidates for epidermal growth factor receptor (EGFR), Her2, and Bruton's tyrosine kinase (Btk).  Here we review recent pre-clin. and clin. advances with targeted covalent kinase inhibitors, and the potential for broader application of the approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQb40Eok-vbVg90H21EOLACvtfcHk0lgUpwzTl61m_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr8%253D&md5=ee3b8b9e0c6ec317f975a426cf08428f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.168%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DKluge%26aufirst%3DA.%2BF.%26atitle%3DTargeted%2520covalent%2520drugs%2520of%2520the%2520kinase%2520family%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D475%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1038%2Fnchembio.492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21113170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=22-24&author=M.+Hagelauthor=D.+Niuauthor=M.+T.+Stauthor=M.+P.+Sheetsauthor=L.+Qiaoauthor=H.+Bernardauthor=R.+M.+Karpauthor=Z.+Zhuauthor=M.+T.+Labenskiauthor=P.+Chaturvediauthor=M.+Nachtauthor=W.+F.+Westlinauthor=R.+C.+Petterauthor=J.+Singh&title=Selective+irreversible+inhibition+of+a+protease+by+targeting+a+noncatalytic+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine</span></div><div class="casAuthors">Hagel, Margit; Niu, Deqiang; St. Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-24</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic app.  We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family.  We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLcCQdERpWWLVg90H21EOLACvtfcHk0lgUpwzTl61m_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsb3M&md5=e2b523ebc4e1115beef32093003a10c9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.492%26sid%3Dliteratum%253Aachs%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DSt%26aufirst%3DM.%2BT.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLabenski%26aufirst%3DM.%2BT.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DSelective%2520irreversible%2520inhibition%2520of%2520a%2520protease%2520by%2520targeting%2520a%2520noncatalytic%2520cysteine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D22%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2714</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.2174%2F092986711796011229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=21649578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2686-2714&author=S.+J.+Shuttleworth&title=Progress+in+the+preclinical+discovery+and+clinical+development+of+class+I+and+dual+class+I%2FIV+phosphoinositide+3-kinase+%28PI3K%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors</span></div><div class="casAuthors">Shuttleworth, S. J.; Silva, F. A.; Cecil, A. R. L.; Tomassi, C. D.; Hill, T. J.; Raynaud, F. I.; Clarke, P. A.; Workman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2686-2714</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinases (PI3Ks) constitute an important family of lipid kinase enzymes that control a range of cellular processes through their regulation of a network of signal transduction pathways, and have emerged as important therapeutic targets in the context of cancer, inflammation and cardiovascular diseases.  Since the mid-late 1990s, considerable progress was made in the discovery and development of small mol. ATP-competitive PI3K inhibitors, a no. of which have entered early phase human trials over recent years from which key clin. results are now being disclosed.  This review summarizes progress made to date, primarily on the discovery and characterization of class I and dual class I/IV subtype inhibitors, together with advances that were made in translational and clin. research, notably in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpibTyG_ua2WLVg90H21EOLACvtfcHk0ljGR_hgJzznuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73M&md5=baf93d773ce18eb70ebc5549c14f422c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986711796011229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011229%26sid%3Dliteratum%253Aachs%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520preclinical%2520discovery%2520and%2520clinical%2520development%2520of%2520class%2520I%2520and%2520dual%2520class%2520I%252FIV%2520phosphoinositide%25203-kinase%2520%2528PI3K%2529%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2686%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=L.+M.+Amzel&title=The+structure+of+a+human+p110alpha%2Fp85alpha+complex+elucidates+the+effects+of+oncogenic+PI3Kalpha+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520structure%2520of%2520a%2520human%2520p110alpha%252Fp85alpha%2520complex%2520elucidates%2520the%2520effects%2520of%2520oncogenic%2520PI3Kalpha%2520mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.+Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-t hieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-t+hieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lgJhPxVtu6ZjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-t%2520hieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ikediobi, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthorpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackenbury, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hills, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosmidou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mironenko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tofts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widaa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span> </span><span class="NLM_article-title">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2606</span><span class="NLM_x">–</span> <span class="NLM_lpage">2612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3008745&amp;key=10.1158%2F1535-7163.MCT-06-0433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3008745&amp;key=17088437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3008745&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2606-2612&author=O.+N.+Ikediobiauthor=H.+Daviesauthor=G.+Bignellauthor=S.+Edkinsauthor=C.+Stevensauthor=S.+O%E2%80%99Mearaauthor=T.+Santariusauthor=T.+Avisauthor=S.+Barthorpeauthor=L.+Brackenburyauthor=G.+Buckauthor=A.+Butlerauthor=J.+Clementsauthor=J.+Coleauthor=E.+Dicksauthor=S.+Forbesauthor=K.+Grayauthor=K.+Hallidayauthor=R.+Harrisonauthor=K.+Hillsauthor=J.+Hintonauthor=C.+Hunterauthor=A.+Jenkinsonauthor=D.+Jonesauthor=V.+Kosmidouauthor=R.+Luggauthor=A.+Menziesauthor=T.+Mironenkoauthor=A.+Parkerauthor=J.+Perryauthor=K.+Raineauthor=D.+Richardsonauthor=R.+Shepherdauthor=A.+Smallauthor=R.+Smithauthor=H.+Solomonauthor=P.+Stephensauthor=J.+Teagueauthor=C.+Toftsauthor=J.+Varianauthor=T.+Webbauthor=S.+Westauthor=S.+Widaaauthor=A.+Yatesauthor=W.+Reinholdauthor=J.+N.+Weinsteinauthor=M.+R.+Strattonauthor=P.+A.+Futrealauthor=R.+Wooster&title=Mutation+analysis+of+24+known+cancer+genes+in+the+NCI-60+cell+line+set"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation analysis of 24 known cancer genes in the NCI-60 cell line set</span></div><div class="casAuthors">Ikediobi, Ogechi N.; Davies, Helen; Bignell, Graham; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Santarius, Thomas; Avis, Tim; Barthorpe, Syd; Brackenbury, Lisa; Buck, Gemma; Butler, Adam; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kristian; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jonathan; Hunter, Chris; Jenkinson, Andy; Jones, David; Kosmidou, Vivienne; Lugg, Richard; Menzies, Andrew; Mironenko, Tatiana; Parker, Adrian; Perry, Janet; Raine, Keiran; Richardson, David; Shepherd, Rebecca; Small, Alex; Smith, Raffaella; Solomon, Helen; Stephens, Philip; Teague, Jon; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Reinhold, William; Weinstein, John N.; Stratton, Michael R.; Futreal, P. Andrew; Wooster, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2606-2612</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer Institute for anticancer drug discovery is a widely used resource.  The NCI-60 has been characterized pharmacol. and at the mol. level more extensively than any other set of cell lines.  However, no systematic mutation anal. of genes causally implicated in oncogenesis has been reported.  This study reports the sequence anal. of 24 known cancer genes in the NCI-60 and an assessment of 4 of the 24 genes for homozygous deletions.  One hundred thirty-seven oncogenic mutations were identified in 14 (APC, BRAF, CDKN2, CTNNB1, HRAS, KRAS, NRAS, SMAD4, PIK3CA, PTEN, RB1, STK11, TP53, and VHL) of the 24 genes.  All lines have at least one mutation among the cancer genes examd., with most lines (73%) having more than one.  Identification of those cancer genes mutated in the NCI-60, in combination with pharmacol. and mol. profiles of the cells, will allow for more informed interpretation of anticancer agent screening and will enhance the use of the NCI-60 cell lines for molecularly targeted screens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1IovOJtJWDbVg90H21EOLACvtfcHk0lhVOCMb2hsSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1els7jK&md5=f943d16d3e147357815de0ec3c29c30d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0433%26sid%3Dliteratum%253Aachs%26aulast%3DIkediobi%26aufirst%3DO.%2BN.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%26aulast%3DEdkins%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DS.%26aulast%3DSantarius%26aufirst%3DT.%26aulast%3DAvis%26aufirst%3DT.%26aulast%3DBarthorpe%26aufirst%3DS.%26aulast%3DBrackenbury%26aufirst%3DL.%26aulast%3DBuck%26aufirst%3DG.%26aulast%3DButler%26aufirst%3DA.%26aulast%3DClements%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DDicks%26aufirst%3DE.%26aulast%3DForbes%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DHalliday%26aufirst%3DK.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHills%26aufirst%3DK.%26aulast%3DHinton%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DC.%26aulast%3DJenkinson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKosmidou%26aufirst%3DV.%26aulast%3DLugg%26aufirst%3DR.%26aulast%3DMenzies%26aufirst%3DA.%26aulast%3DMironenko%26aufirst%3DT.%26aulast%3DParker%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DRaine%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DShepherd%26aufirst%3DR.%26aulast%3DSmall%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DSolomon%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26aulast%3DTofts%26aufirst%3DC.%26aulast%3DVarian%26aufirst%3DJ.%26aulast%3DWebb%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWidaa%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMutation%2520analysis%2520of%252024%2520known%2520cancer%2520genes%2520in%2520the%2520NCI-60%2520cell%2520line%2520set%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D2606%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Krenske, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Transition states and energetics of nucleophilic additions of thiols to substituted alpha,beta-unsaturated ketones: substituent effects involve enone stabilization, product branching, and solvation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">5074</span><span class="NLM_x">–</span> <span class="NLM_lpage">5081</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo200761w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=5074-5081&author=E.+H.+Krenskeauthor=R.+C.+Petterauthor=Z.+Zhuauthor=K.+N.+Houk&title=Transition+states+and+energetics+of+nucleophilic+additions+of+thiols+to+substituted+alpha%2Cbeta-unsaturated+ketones%3A+substituent+effects+involve+enone+stabilization%2C+product+branching%2C+and+solvation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo200761w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo200761w%26sid%3Dliteratum%253Aachs%26aulast%3DKrenske%26aufirst%3DE.%2BH.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DTransition%2520states%2520and%2520energetics%2520of%2520nucleophilic%2520additions%2520of%2520thiols%2520to%2520substituted%2520alpha%252Cbeta-unsaturated%2520ketones%253A%2520substituent%2520effects%2520involve%2520enone%2520stabilization%252C%2520product%2520branching%252C%2520and%2520solvation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D5074%26epage%3D5081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zim" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zim','PDB','3zim'); return false;">PDB: 3zim</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS','PDB','3DBS'); return false;">PDB: 3DBS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0','PDB','2RD0'); return false;">PDB: 2RD0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/jm3008745">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84802"></div></div></div></div></div><hr /></hr><p class="last">Chemical structure of the covalent probe <b>8</b>; mass spectrometry on <b>3</b> with PI3K family members; specificity of <b>3</b> toward PI3Kα vs other kinases; lack of reactivity of <b>3</b> to nonspecific thiols including glutathione and plasma proteins; inhibition of PI3Kα signaling in SKOV3 cells by <b>3</b>; specificity of the covalent probe <b>8</b> for PI3Kα vs PI3Kβ in vitro; X-ray crystallography parameters of <b>3</b> complexed with PI3Kα. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3008745/suppl_file/jm3008745_si_001.pdf">jm3008745_si_001.pdf (599.17 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3008745&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm3008745" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3008745" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997c28dff62374","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
